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ABSTRACT
CHEMICAL BIOLOGY-BASED PROBES FOR THE DETECTION OF RECEPTORS
ON LIVE CELLS
SEPTEMBER 2015
AMANDA M. HUSSEY
B.S., UNIVERSITY OF THE SCIENCES IN PHILADELPHIA
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor James J. Chambers

Proper detection is the key to studying any processes on the cellular scale.
Nowhere is this more evident than in the tight space which confines the synaptic cleft.
Being able to ascertain the location of receptors on live neurons is fundamental to our
understanding of not only how these receptors interact and move inside the cell but also
how neurons function. Most detection methods rely on significantly altering the receptor;
both tagging with a fluorescent protein or targeting the receptor by a fluorescent reporter
in the form of a small molecule causes significant difficulties. These localization
techniques often result in forced dimerization, unnatural movement, and at worst
inactivation of the receptor.
Small molecule organic dyes provide a potential advantage because they can be
structurally functionalized to target the protein of interest in a non-perturbing fashion
which allows for information to be gathered about the targeted receptor. The work I
initiated in the Chambers lab first focused on using a ligand directed fluorophore
connected via a photo-labile linker. Through the use of epifluorescence microscopy, I
determined that this probe targets glutamate receptors, however questions about subtype
inclusion could not be addressed.

vi

The pharmacophore that our first probe is based on could be much more
promiscuous than is presently appreciated in the field of neurobiology.

Thus, we

designed a new series of probes to allow for covalent modification and affinity
purification of endogenous receptors. The second generation of probes set out to answer
the questions left by the first. Purified proteins were subjected to SDS-PAGE analysis
and could be applied to proteomic identification of receptors.
In addition to ligand directed probes, we have also initiated a project on a new,
bimolecular photoaffinity probe in which the new methodology continues to develop. The
initial studies were performed to ensure that our new strategy is able to be used in
biological systems.
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CHAPTER 1
INTRODUCTION
Portions of this chapter have been published as Hussey, A.M. and Chambers, J.J. ACS Chem.
Neurosci. 2015 6(1), pp189-98
1.1 Neuronal Structure
The brain is a complex organ composed of 1,000,000s of neurons which interface
with each other in order for the body to function. Neurons are post-mitotic, highly
polarized cells which transmit information through chemical and electrical signals.
Neurons contain three major morphological regions: a soma, or cell body, which contains
the nucleus and other cytoplasmic organelles, a single axon which extends from the cell
body to transmit neuronal information, and numerous dendrites which may be spiny or
non-spiny which receive information. (Figure 1.1)1

Figure 1.1: Annotated image of a neuron
Neurons communicate via transfer of electrochemical signals from the axon
terminal to the dendrites. This area is called a synapse. The axon terminal of one neuron
acts as the presynaptic portion of the synapse, while the dendrite acts as the post-synaptic
portion. The space in-between is the synaptic cleft, which measures to be about 20 nm in
1

size.2 It is in this area where neurotransmitter receptors reside and synaptic
communication takes place.
1.1.2 Synaptic Communication and Plasticity
Neuronal communication involves the transfer of neurotransmitter from the presynaptic side of one neuron to the post-synaptic side of another neuron. It is on the postsynaptic side where neurotransmitter receptors and ion channels reside. (Figure 1.2)

Figure 1.2: Cartoon image of synaptic communication. Neurotransmitter flows
from the pre-synaptic side of one neuron to the post-synaptic side of
another. Neuronal receptors reside on the postsynaptic side to receive
the neurotransmitter. Reprinted with permission from Hussey, A.M. and
Chambers, J.J. ACS Chem. Neurosci.2015 6(1), pp189-98. Copyright
2015 American Chemical Society.
How the synapse strengthens or weakens in response (e.g. the addition or
removal of neuronal receptors from synapse) to a chemical response is termed synaptic
plasticity, which can be controlled on either side of neuronal communication. On the
presynaptic side, the flow of neurotransmitter can be regulated. On the postsynaptic side,
the type and density of receptors is regulated. Regulation on the post synaptic side either
adds more neuronal receptors, known as long term potentiation (LTP), or removes
2

receptors, known as long term depression (LTD).3 Both LTP and LTD are thought to
underlie memory formation in the brain. α-amino-3-hydroxy-5-methyl-4-isoxazole
propionic acid receptors (AMPARs) are the critical receptors which mediate fast
excitatory synaptic processes during LTP. Thus, the mechanism of how these receptors
are trafficked is of fundamental importance.
1.1.3 Long Term Potentiation
LTP involves the insertion into the plasma membrane and the rapid recycling of
AMPARs through the endosomal systems (Figure 1.3). Until very recently, LTP was
thought to be mediated by the insertion of GluA1-containing AMPARs into the synaptic
membrane, thus, there is a large amount of characterization of these processes. The
combination of calcium being tightly regulated by all cells and the low abundance of
calcium permeable AMPARs on the surface lead to the thought that these receptors play a
minor role in LTP. However, calcium permeable AMPARs have now been shown to
play a larger role than originally thought in LTP, though the mechanism of how is not
well understood.4
A key player in long term potentiation is phosphorylation of AMPARs by protein
kinases.5 One particular class of kinases thought to be important in LTP are the
Ca2+/calmodulin-dependent protein kinases (CaMK), specifically, CaMKII. AMPAR
conductance is increased when CaMKII phosphorlylates GluA1 at S831 directly which
may induce LTP.6 Another key kinase is protein kinase A (PKA), which phosphorylates
GluA1 at S845. Phosphorylation at this latter site allows for the increased chance of the
channel opening, thus more neurotransmitter to go through the channel.7 Phosphorylation
of GluA1 S845 also allows for some of the delivery of GluA1 to synapses, as well as to
the extrasynaptic membrane.8 Synaptic associated protein 97 kDa (SAP97) is in the
PSD95-like membrane-associated guanylate kinase family, and has been found to be

3

important during LTP. It binds to the C-teminus of GluA1 and plays a role in the
phosphorylation of GluA1, leading to enhancement of LTP.5b

Figure 1.3: Cartoon of LTP. The pre-synaptic side of one neuron releases
neurotransmitter to the post-synaptic side of another. This is thought to be
pivotal in memory formation.

In pyramidal neurons, LTP induces transient and rapid insertion of GluA2lacking calcium-permeable AMPARs into the membrane presumably to enhance the
received signal from the presynaptic terminal.9 The exact mechanisms of how calcium
permeable AMPARs are trafficked to the surface are still under investigation. Addiction
studies with cocaine in mice have shown there is an increase in the number of calcium
permeable AMPARs found at the synaptic membrane after initial drug-dose exposure. It
is believed that the overall number of AMPARs does not increase; rather, calcium

4

permeable ones replace calcium impermeable ones. This creates a long-lasting plasticity,
even after a single injection, possibly underlying some of the addictive seeking
behavior.10
1.1.4 Long Term Depression
LTD is the removal of AMPARs from the plasma membrane. This can be done
through either endocytotic processes or internalization of the receptors. Endocytosis can
be done through a clathrin–dependent method in which the AMPARs are removed for
possible intracellular sorting.11 The mechanisms of LTD are harder to pin down, as most
evidence shows that LTD is caused by endocytosis of AMPARs. However, there are
many factors that could cause endocytosis and internalization resulting from provocation
from stimuli such as calcium influx, calcineurin, synaptic activity, ligand binding, and
insulin influx. These stimuli can result in synaptic vesicle endocytosis and endocytosis of
AMPARs to the early endosome, which can be hard to differentiate from that caused by
LTD in cultured cells. 8, 11-12

Figure 1.4: Cartoon of LTD. Fewer receptors are present on the
surface of the post-synaptic side of the receptor. It is a synaptic
pruning process which occurs during sleep.
5

Glutamate receptor interacting proteins (GRIP1 and GRIP2) are another class of
proteins which aid in trafficking of AMPARs during synaptic plasticity. In LTD,
phosphorylation of S880 and Y886 on GluA2 disrupt the binding of GRIP1, allowing for
internalization of AMPARs, thus reducing the numbers in the synapse.13 GluA2 can also
interact with clathrin adaptor protein AP-2, which leads to the NMDA-induced
internalization of AMPARs in an LTD like fashion.8 PICK1 is another protein that plays
a role in the LTP/LTD cascade. The interaction GluA2 and PICK1 is critical in leading
to LTD 14, thus prompting the idea that PICK1 removes GluA2 containing AMPARs
from the synapse.15
1.1.5 Glutamate Receptors
There are many classes of neurons including inhibitory, excitatory, and
neuromodulary. Both inhibitory and excitatory neurons can be further broken down into
neurons that make local contacts and those that make distant contacts.1 Inhibitory neurons
include GABAergic neurons, medium spiny neurons in the basal ganglia and Pukinje
cells, just to name a few. These neurons are characterized by small, localized projections
which help to regulate excitatory neurons. Excitatory neurons include pyramidal neurons
and spiny stellate neurons found in the cortex. These cells project both locally in the
cortex and make long range connections into different neuronal areas. They are
responsible for carrying the electrochemical communications within the brain.1
Fast excitatory glutamatergic transmission is exclusively mediated in the central
nervous system (CNS) by ionotropic glutamate receptors (iGluRs). These include kanaite
receptors (KA), n-methyl-d-aspartate receptors (NMDARs), and α-amino-3-hydroxy-5methyl-4-isoxazole propionic acid receptors (AMPARs). IGluRs are characterized as
tetramers which are encoded by 18 genes. Several of these genes undergo alternative
splicing and RNA editing. All iGluRs are encompassed by three distinct domains: an

6

extracellular N-terminus, a central transmembrane domain, and an intracellular Cterminus domain (Figure 1.5).8, 16

Figure 1.5: Cartoon representation of iontropic glutamate receptor in the membrane.
All iGluRs follow the same orientation with the N-terminus and ligand
binding domain in the extracellular space, four transmembrane domains, and
the C-terminus in the intracellular space.

7
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Figure 1.6: Structures of glutamate analogues AMPA,
NMDA, and kainic acid

1.1.6 Kainate Receptors
Kainate receptors are a subclass of glutamate receptors named for their activation
by the synthetic agonist kainic acid (Figure 1.6). They are tetramers of GluK1-GluK5 and
their main function is to modulate neuronal excitability and synaptic transmission. They
differ from other ionotropic glutamate receptors, as they are located in pre-synaptic
terminals rather than the post-synaptic terminals.16a Kainate receptors are generally
calcium impermeable, but there is evidence of a calcium permeable form.
1.1.7 NMDARs
NMDARs are named for their activation by the synthetic analogue of glutamate,
n-methyl-d-aspartate (Figure 1.6), and are important regulators of synaptic plasticity.
They form obligate heteromers of GluN1, GluN2A-GluN2D, GluN3A, or GluN3B in a
tetrameric fashion. Channel composition combinations include two GluN1 and two
GluN2A-GluN2D subunits, and two GluN subunits with one GluN2A-D subunit and one
GluN3 subunit. Once assembled, they act as Ca2+ permeable channels, which require both

8

glutamate and glycine for activation.16a NMDA receptors are blocked by extracellular
Mg2+ ions which blocks the channel so that there is little ion flux through it in the absence
of post-synaptic depolarization, allowing for a crucial role in activity dependent synaptic
communication.17
1.1.8 AMPARs
AMPA receptors are named for their sensitivity towards the glutamate analogue
α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (Figure 1.6). They are the most
abundant of the ionotropic glutamate receptors and mediate excitatory neurotransmission.
They assemble as either homo or heterotetramers of GluA1-GluA4, which share 68-73%
sequence identity.18 The most common of the tetrameric pairings are those containing
GluA1-GluA2 and GluA2-GluA3.8 AMPARs have some calcium permeability (discussed
in section 1.1.9) and are impermeable to Mg2+.16a AMPARs have an inwardly rectifying
current, which can be blocked by the application of polyamine toxins (described in
section 1.1.11).
Like other glutamate receptors, AMPARs contain an extracellular N-terminus,
central transmembrane domain, and intracellular C-terminus. The central transmembrane
domain can be further broken down into three distinct transmembrane portions M1, M3,
and M4, as well as an M2 hairpin structure which changes the direction so it returns to
the intracellular side of the cell (Figure 1.5).8, 18 There are two subforms of each subunit,
referred to as “flip” and “flop”, as they vary by an interchangeable 38 amino acid
sequence before the M4 transmembrane portion.18-19
Assemblies of AMPARs start in either the endoplasmic reticulum (ER) or the
Golgi apparatus and are trafficked to the plasma membrane. In the ER, the C-terminus is
subjected to palmitoylation, phosphorylation, and ubiquination for regulation. The Cterminus is also the site where signaling molecules (such as protein interacting with
kinase C, PICK) and cytoskeletal proteins (such as kinesin) bind, aiding in insertion into
9

either the soma or synapses.3, 20 These receptors are then in a dynamic equilibrium with
the synapse.17, 20 The amount of receptors is variable dependent upon location and cell
type, and is also dependent upon endo and exocytosis at the postsynaptic membrane.3, 8
AMPARs are known to move in endosomes in a recycling process that first involves
endocytosis of the receptor, then entry into the endosomal system, and then final
movement back to the receptor surface.4
AMPAR assemblies are controlled not only by posttranslational modifications,
such as phosphorylation of key residues on the individual subunits, but also by regulatory
proteins. One of the key classes of proteins to act as AMPAR regulators are
transmembrane AMPAR regulatory proteins (TARPs). There have been many TARPs
identified, including stargazin (ɣ-2), ɣ-3,-4,-5,-7, and -8.21 Each AMPAR is thought to
contain 1-4 TARPs for stabilization of their pore, and each TARP influences the behavior
of the particular AMPAR.21a, 21c Stabilization of synapses by TARPs is via interaction
with PSD-95 and other membrane-associated guanylate kinases (MAGUKs) that are
present, as TARPs bind to the PDZ domain on each.22 TARPs influence AMPAR
behavior in a variety of ways including increasing single channel conductance, slowing
deactivation and desensitization, modification of pharmacological properties by making
kainate a better agonist, and, perhaps most importantly to this dissertation, attenuating
voltage-dependent blocks by endogenous polyamines.21a, 23 TARPs are also involved in
AMPAR trafficking, as they promote AMPAR maturation, cellular delivery and
clustering, and are most likely involved in both LTP and LTD.21a-c
AMPARs can insert themselves into the membrane in a couple of different
fashions. First is through kinesin directing endosomes containing AMPARs, and the
second is through vesicle fusion events with SNARE proteins on the surface of the
membrane.24 Once the AMPAR cargo is delivered, the receptor can travel to an active
spine via lateral diffusion.25
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1.1.9 Calcium Permeability in AMPARs
AMPA receptors can either be calcium permeable or calcium impermeable.
Those receptors that contain GluA1, GluA3, and Glu4 combinations are calcium
permeable. Ones which contain GluA2 are generally calcium impermeable. There is a
subclass of calcium permeable AMPA receptors which contain unedited GluA2
receptors, which have been thought to be pivotal in some disease states, such as
amyotrophic lateral sclerosis (ALS). The calcium permeability of GluA2 is mediated by a
single RNA codon edit known as the Q/R site inside the M2 domain of the subunit. Here,
an encoded glutamine is changed to an arginine via a single nucleoside edit. In the
nucleotide code, CAG (glutamine), the encoded adenosine is changed to inosine (CIG),
which is read as CCG (arginine). This edit is mediated by the enzyme adenosine
deaminase acting on RNA (ADAR2), as it recognizes the Q/R site through the formation
of a duplex structure of the editing site and the editing site of the complimentary
sequence.26 This edit occurs postnatally and accounts for only about 1% of the GluA2
RNA. ADAR2 activity is important as ADAR2 knock out (KO) mice die very young
from epilepsy due to the increased amount of calcium influx from the larger population of
unedited GluA2. 18, 27 It is important to note that AMPARs which do contain unedited
forms of GluA2 may be very effective at inducing neurotoxicity, suggesting their role in
the disease states mentioned in section 1.4. 28
The populations of calcium permeable AMPA receptors are not consistent or
uniform, but are highly dependent on developmental stage of the neurons as well as cell
type. For example, inhibitory interneurons contain larger amounts than that of mature
excitatory neurons.17, 29 However, immature excitatory neurons (e.g. postnatal culture)
have high populations of calcium permeable AMPARs.30 The number of calcium
permeable AMPARs can increase due to pathological and physiological conditions found
in the brain, meaning that in times of stress and disease, their numbers can increase
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greatly. This induced stress from the extra calcium makes it harder for the neuron to
regain normal function thus they might perish.
Calcium permeable AMPARs, unlike NMDARs, are not subject to blocks by
extracellular cations, such as Mg2+, but are subject to voltage dependent block by
polyamines. They are also permeable towards other divalent cations, specifically Zn2+.
Zn2+ is toxic to neurons and can enter through calcium permeable channels. The entry of
Zn2+ can lead to ischemic like injury and neurodegeneratation.17, 31
1.1.10 Calcium Permeable AMPA Receptors in Excitatory Disease
AMPA receptors are involved in a number of disease states. This is influenced by
a number of factors including influx of calcium, certain drugs (such as cocaine), disease
progression, and ischemic trauma.
Forty percent of patients, who are being treated with l-DOPA for Parkinson’s
disease, and other similar diseases, will develop l-DOPA induced dyskinesia which is
linked to pathological corticostriatal synaptic plasticity such as altered expression of
striatal opioid peptides. This presents enhanced corticostriatal glutamatergic transmission
by which the mechanism and expression of l-DOPA induced dyskinesia plays a critical
role. Animal studies have shown that AMPARs may be present during these induced
dyskinesias as enhanced trafficking and phosphorylation of AMPARs in the striatum was
present.32
More recently, GluA2 containing calcium permeable AMPA receptors have been
implicated as a potential cause of ALS. ALS has a couple of different disease
phenotypes; the most well studied being the familial form which has defects in copper
zinc superoxide dismutase 1 (SOD1) known as ALS1. Familial cases of ALS only
compose 10% of all new ALS diagnoses, so there is ultimately another mechanism, or
mechanisms, of how the disease initiates and progresses. It is also noteworthy that the
death inducing molecular mechanisms differ between sporadic ALS and ALS1, as those
12

who have sporadic ALS do not share the same disease causative mutations that are
characteristic of ALS1. Also, those who have ALS1 lack the accumulation of TDP-43
(transactive response DNA binding protein 43 kDa), a transcriptional protein whose
ubiquinated, phosphorylated form is a marker for ALS 33 which is seen in patients having
sporadic ALS. 27 Transgenic animal studies have suggested a role of GluA2 containing
calcium permeable AMPA receptors as there is a large amount of motor neuron loss in
these animals. Crosses of SOD1 mutant mice and mice which contain a nonlethal calcium
permeable GluA2 edit (asparagine in the Q/R site) lead to acceleration in the disease.27, 34
Analysis of brain samples from ALS patients after autopsy show a decreased amount of
ADAR2 mRNA in the ventral grey matter compared to those of who are nonsymptomatic for ALS, thus showing a possible correlation of ADAR2 reduction and
motor neuron death due to inefficient editing of the Q/R site.27
Calcium permeable AMPARs are involved in brain ischemias, or loss of blood
flow to the brain leading to reduced metabolic rates, and ultimately total neuronal death.
When present in early brain development, there is an increased rate of neuronal death in
the white and grey matter coinciding with the times that there are a marked increase in
the numbers of calcium permeable AMPARs present, suggesting the link of these
receptors to ischemic susceptibility.35 Ischemia can also be present after cardiac arrest,
resulting in damage to, and potential loss of, of neurons. Pyramidal neurons in the
hippocampus are particularly vulnerable to this type of injury. The amount of calcium
permeable AMPARs rises after ischemia, resulting in a greater injury due to the ischemic
event, and ultimately neuronal death due to the induction of Ca2+ permeability.17, 36
1.1.11 Polyamine Toxins as Tools in Neurobiology
Polyamine toxins have become a key tool as antagonists of calcium permeable
AMPA receptors. AMPA receptors, specifically calcium permeable ones, are subjected to
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voltage dependent blocks by polyamines, but are not blocked by extracellular cations.
This allows for the free flow of Ca2+ through the channel.37
Polyamine toxins (Figure 1.7) are low molecular weight secondary metabolites
which have mainly been isolated from the venom of spiders and wasps. These toxins are
not deadly; rather they have a reversible paralytic effect. Argiotoxin-636 (Arg-TX-636)
was the first isolated polyamine toxin isolated from the venom of the orb weaver spider.
Next came Joro spider toxin (JSTX-3), isolated from the spider of the same common
name. The venom of the Egyptian digger wasp was known to block iGluRs since the
early 1980’s, its isolation of the active component, philanthotoxin-433, provided another
toxin.38 All of these toxins share two structural moieties in common; an aromatic head
group and a polyamine tail, which then enabled the synthesis of napthylacetylspermine, a
synthetic polyamine.39 All act as open-channel ion blockers of iGluRs, are use-dependent,
and voltage-dependent coming from the polyamine blocking the inward current of the
AMPAR channel. The use-dependence comes from the ion channel needing to be open
for targeting by the exogenous polyamine application. It is important to re-iterate that this
is true of all AMPARs which do not contain an edited GluA2 subunit. The presence of
the arginine in the channel will not allow for binding of the polyamine into the ion
channel due to charge repulsion.38a, 40
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Figure 1.7: Structures of polyamine toxins with activity towards AMPARs.
The common moieties of the aromatic acyl head group and the
polyamine tail are pointed out in the box
Binding of polyamine toxins to ion channel pores has been explored through a
variety of molecular modeling and structure-activity experiments as there is no X-ray
crystal structure data available for precise details of the full AMPA receptor. However, a
crystal structure is available of the GluA2 subunit.41 From the collected data, polyamine
toxins are suggested to bind so that the polyamine tail binds into the ion pore and the
acryl head acts as a block to the ion channel.42
1.2 Imaging Techniques
Small molecule fluorophores and proteinaceous fluorophores have been the main
tools used in the visualization of ion channels, neuronal receptors, and other targets on
live neurons. The main methods for visualization can be divided into two broad
categories; genetic methods and non-genetic methods. Genetic methods involve encoding
the receptor of interest to produce either a fluorescent reporter or a small tag for
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attachment of a fluorophore. Non-genetic methods involve the delivery of biological or
small molecule reporters for visualization. This can be summarized by Figure 1.8

Figure 1.8: Size comparison of common protein tags. All of the common protein tags for
visualization of neuronal receptors (antibodies, GFP, HaloTag, Snap Tag, quantum
dots, and tetracysteine motifs) have been scaled relative to the size of an AMPAR.
The size comparisons for small molecule organic probes are in the right panel.
Reprinted with permission from Hussey,A.M. and Chambers, J.J. ACS Chem.
Neurosci. 2015 6(1), pp189-98. Copyright 2015 American Chemical Society.
1.2.1 Genetic Imaging Techniques
Genetic imaging techniques have benefited greatly from the discovery of
fluorescent proteins (FPs). FPs can be encoded into to the DNA of a protein of interest
which can then be transfected into a cell. Recently, FPs have been used to visualize
neurons and glia in 90 different colors in zebrafish, drosophila, and mice in a technique
known as Brainbow, which allows for the serial reconstruction of connectivity through
the stochastic expression of cytosolic FPs. This is done through a Cre/Lox recombination
which determines the pattern and colors that are expressed, allowing for the visualization
of neuronal connectivity in a given system.43 FPs are more commonly used as fluorescent
fusion proteins which are then transfected into a particular system of interest, thus
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allowing for the visualization of the receptor of interest as the protein is covalently tagged
to the protein of interest. This has been done numerous times to determine receptor
surface expression, how receptors are endo/exocytosed, and to interrogate the biophysical
properties of a particular ion channel.43b, 44 Fusion proteins can be quite small, but most
are based on the GFP (green fluorescent protein) template developed by Tsein et al.45
1.2.2 Fluorescent Proteins
GFP ushered in a new age in which many biological advances have and can be
made. GFP, itself, is a 28 kDa protein which is added to the receptor of interest in a
fashion which allows for the particular receptor to still remain functional. This is done by
adding GFP as either a fusion to the N or C terminus or added into a loop on the protein.
This can then result in non-native heteromultimers or homomultimers when the receptors
assemble. Also, the addition of GFP (and variants) can disrupt normal receptor motion,
which will provide no information about receptor dynamics.43b, 46
1.2.3 Enzymatically Active Tags
One way to circumvent some of the issues presented by FPs, is to use
enzymatically active tags such as SNAP, CLIP, and Halo tags. SNAP and CLIP tags
involve the incorporation of a derivative of O6-alkyl guanine-DNA alkyltransferase
(AGT), a 20 kDa DNA repair protein, which can be inserted to the protein of interest.
For SNAP-tag technology, modifications to the protein are delivered via the intrinsic
activity of the tag and synthetic derivatives of O6-benzylguanine that have been modified
to contain cargo such as fluorophores.47 O6-benzylguanine probes act as a substrate to the
tag, delivering cargo to a reactive cysteine in the AGT active site. CLIP-tag reacts in the
same fashion, but contains mutations to AGT so that it will interact with derivatives of
O2-benzylcytosine.48 SNAP and CLIP tags have been used in numerous systems to track
subunit assembly and stoichiometry. Much like FPs, SNAP and CLIP tags suffer from the
same issues of complications in the natural assembly and protein dynamics.
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HaloTag is a labeling technology that is derived from modified bacterial
haloalkane dehalogenase. It is a large tag, approximately 34 kDa, and needs to be
attached to the protein of interest via a 16 amino acid linker derived from the tobacco
mosaic virus.49 Once fused to the protein of interest, HaloTag is targeted by a separate
reporter probe containing a haloalkane. HaloTag works by alkylation of the reporter
probe to the protein of interest affixed with HaloTag, resulting in the formation of an
ester bond at a catalytic aspartate on the carboxylate. The modification that allows for
this to happen is a mutation of a crucial histidine near the catalytic aspartate leaves the
transient covalent ester intact, allowing for the reporter probe to attach to HaloTag.50 The
linker length between the haloalkane and the reporter (fluorescein, tetramethylrhodamine,
Alex 288, Dy633, Oregon green, etc.) is crucial for the optimum performance of
HaloTag. The optimal linker length was found to be six carbons, when terminated with a
chloride. HaloTag has been utilized to measure retrograde axonal transport and to look at
some of the basis of cell mediated autophagy.43b, 51 HaloTag suffers from the same
disadvantages as FPs, SNAP and CLIP tag, however it has been reported that the large
tag size does not disrupt protein function.52
Similar to enzymatically active tags are enzymatic substrate tags. This
technology was pioneered by the Ting lab and involves the attachment of a 15 amino acid
acceptor peptide to the protein of interest and then is targeted by a substrate sequence that
is exogenously expressed biotin ligase resulting in bioconjugation of a peptide with biotin
which then can be targeted by a streptavidin labeled moiety. This biotin ligase based
strategy has been used in conjunction with HaloTag for use in single molecule live cell
imaging.53
1.2.4 Small, peptide-based tags
The use of small, peptide based tags is another genetic technique that averts the
need for FPs or enzymatic tags. These include tetracysteine motifs, poly-histidine tags,
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and Ni-NTA tags. The most widely used of the small, peptide tags are tetracysteine
motifs. Tetracysteine motifs, as the name suggests, insert a small peptide sequence which
contains four cysteines (C-C-X-X-C-C) to the protein of interest in a non-perturbing
fashion. The added tetracysteine sequence can then be targeted by a fluorophore which
contains a biarsenical core, taking advantage of the high affinity between the sulfurs in
the cysteine and the arsenic. This can then allow for the location and dynamics of the
protein to be measured. Tetracysteine motifs are also used because there is generally a
lack of arsenic in proteins, and the multivalency that is given between the four encoded
cysteines to a single arsenic in the reporter.54 The biarsenical reporter tag comes in a
variety of colors, including green, red, and blue (FlAsH, ReAsH, and XoXAsH).54-55 In
2007, Bhunia et al expanded the pallet even further through the use of SplAsH, which can
incorporate a fluorophore of any color on to the arsenic core.56
Tetracysteine motifs have been used in conjunction with FlAsH in imaging using
either chromophore-assisted laser inactivation (CALI) or fluorophore-assisted laser
inactivation (FALI), which allows for perturbations to the system and collect
observations from that set time point.57 FlAsH and ReAsH have been used in
combination to examine the intracellular trafficking of GluA1 and GluA2 subunits. This
was done by inserting the tetracysteine motif on the C-terminus and thus could report on
protein synthesis in these two subunits.58
Tetracysteine motifs do have some caveats, chiefly that there is a low level of
specificity when using the whole system in cysteine rich environments. The biarsenical
detection ligand does not discriminate between that of the added tetracysteine motif and
the endogenous cysteine rich areas on the protein. This can lead to misdirection of the
biarsenical targeting ligand; thus confounding the imaging outcome as it will be a
mixture of the desired protein and the non-desired cysteine rich one.43b

19

1.2.5 Antibodies
Antibodies are exquisitely specific towards their target of interest and thus are an
extremely useful diagnostic tool for protein interactions. Antibodies are the bridge
between genetic and non-genetic techniques as they contain aspects from each.
Antibodies are genetic in the sense that they are derived from proteins raised to label a
specific epitope on the protein of interest. Antibodies are non-genetic as they need to be
exogenously applied to label the protein of interest, and also may need a secondary
detection for visualization.43b
The use of antibodies mostly involves no genetic manipulation to the protein of
interest when the antibody is raised towards a particular epitope on the receptor.
Antibodies have been used in both live and fixed cell imaging with neuronal targets
providing information on location, quantification, and observation of the dynamic
movements of the neuronal receptors. Antibodies are large proteins, typically measuring
10-15 nanometers in size.59 Primary antibodies typically need to be conjugated with a
secondary antibody for visualization. The synaptic cleft is approximately 20 nanometers,2
so when the antibody complex is placed onto the neurotransmitter of interest and then
targeted by a secondary antibody for visualization, this complex is typically larger than
that of the synaptic cleft. This will then limit the use of antibodies in providing
information about receptor movement at the synapse.
1.2.6 Non-Genetic Imaging Techniques
Non-genetic imaging techniques compose a wide range of molecules that deliver
a fluorophore to the neurotransmitter receptor of interest. This is typically done in a
ligand-directed method that either uses a small molecule, or small peptide, as the delivery
method. Antibodies can also be used as a targeting method. Since non-genetic
techniques are partially synthetic in nature, a wide rainbow of fluorophore colors and
properties can be made available for targeting and subsequent imaging. When designing a
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probe for targeting of neural proteins, many factors need to be considered. The ideal
probe should be selective, non-toxic, water soluble, and robust enough to withstand the
environment inside the cell if used towards intracellular targets. Fluorophore attachment
to either an antibody or the small molecule probe must have the above properties, and
also be able to maintain brightness when bound to the system of interest.43b, 60
1.2.7 Quantum Dots
Quantum dots, QDs, are nano-sized colloid semiconductors which have
properties that are tuned during their synthesis, and thus, can be targeted to a biomolecule
of interest by graphing certain ligands to the surface of the QD. This often relies on the
interaction of biotin and streptavidin 61, acid-base interactions 62, and covalent ligand
attachment to a polymer on the surface of the QD.63 QDs are more photostable than
organic fluorophores and as a result, are brighter. However, QDs are subject to blinking
and this can lead to complications during tracking experiments. Considerations also need
to be made with size, as QDs can vary from 2 nanometers up to 20 nanometers in size
once fully decorated. This would then make QDs the same size as the synaptic cleft.64
Antibodies and QDs have been used in conjunction for long term tracking of
proteins involved in synaptic transmission. This was demonstrated in work tracking
glycine receptors. Antibodies were raised against the glycine receptor and then targeted
with a secondary biotinylated antibody. Visualization of the receptor location in the
soma and dendrites was then achieved by the addition of streptavidin coated QDs. 65
Single particle tracking has been used to observe changes NMDA receptor subtypes 66,
and in live cell imaging of AMPARs via fluorescence-recovery after photoinactivation
experiments.67
1.2.8 Ligand-Based Detection
Ligands, in conjunction with other chemical entities such as fluorophores, have
been used extensively to deliver cargo to the receptor of interest. This can be achieved
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through bioconjugation to the target receptor after directed targeting via a ligand that has
been affixed with a fluorophore for visualization. The modification by the probe can
either be covalent or non-covalent in nature. Ligand based techniques are extremely
useful in helping to determine receptor expression in native culture. Discoveries made by
these techniques may be closer to what is occurring inside the brain.
Our group 68 has designed such a probe for the detection of calcium permeable
AMPA receptors, which is further discussed in detail in Chapter 2. Other ligand-directed
methods for cargo delivery to neurotransmitter receptors of interest modify existing drug
molecules to be decorated with fluorophores via a linker chain that does not interfere with
target binding. Amy Hauck Newman and coworkers at the NIH have developed two such
ligand-directed probes, one for the dopamine transporter (DAT) and one for the serotonin
transporter (SERT), using this method. These probes take an analogue of an agonist for
the particular receptor and decorated it with a fluorophore for visualization. This then
allows for information to be gathered about proteins synthesized inside the native
receptor.69 The Strømgaard group at the University of Copenhagen employed a similar
technique in the development of a NMDA receptor probe by using a NMDA antagonist
attached to a fluorophore. Using this technique, they were able to visualize native, active
NMDA receptors in culture.70
1.2.9 Peptide-Based Ligand Delivery
Much like small molecule ligand delivery, peptide-based ligand delivery has
allowed for gains in knowledge about how receptors traffic inside the brain. Small
peptides can easily be synthesized thus leading to a plethora of peptide-based ligands that
can be optimized rapidly. A synthetic biomimetic peptide based probe was designed by
Choquet and Imperiali to target the PDZ domains at synapse. These domains, located on
the postsynaptic side of the synapse, are believed to govern the general dynamics of
receptors and ion channels to look at the dynamics of AMPA and NMDA receptors. The
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use of these probes provided insight into the 2-4 stoichiometry of the anchoring proteins
of the AMPA receptor.71 As for NMDA receptors, the dynamics of the 2A and 2B
subunits were interrogated via the PDZ biomimetic probe. The results suggest the
anchoring mechanism is different between the two subunits as the 2A subunit was
blocked, but the 2B subunit was not affected. 72
Ligand directed probes, whether small molecule or peptide based, have the
advantage that the ligand drives the specificity of labeling towards the target. The main
limitation of this method is that the ligand may not be as completely specific as designed
and can have known interactions with alternate subunits on the same receptor as well as
interactions with off-target receptors. There are also limitations due to cell permeability
and target location. Some probes will be difficult to deliver inside of cells, some may be
less optimal for visualization, and some may suffer from lack of optimization. A lot of
probes are tested in heterologous systems which lack the complexity and nuance of the
downstream pathways which are found in the native system.
However, small molecule probes offer advantages over genetic techniques. The
targeted receptors do not need to be genetically modified to contain either the FP or a
protein tag. Transfection of these genes cannot always be done efficiently in neurons.
Also, the palate of fluorophores that can be used in combination with small molecule
probes is much wider, as organic fluorophores come in a plethora of colors and
photostablities. Small molecule probes can also be designed in a fashion that should not
disturb the receptor of interest, something that cannot always be said of genetic
techniques. Due to these reasons, we decided to make small molecule probes to target
towards AMPARs.
1.3 Bioorthogonal Chemistry
Bioorthogonal chemistry is any chemical reaction which occurs inside living
biological systems, such as a cell, that does not interfere with normal biochemical
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processes (Figure 1.9).73 This allows for the study of proteins, lipids, glycans, and other
metabolites inside of the host system and gives an idea of how they act in real time.
Bioorthogonal chemistry is an umbrella term which covers a wide subset of reactions
which must have fast reaction rates and be biologically inert. These include 1,3-dipolar
cycloadditions (Click reactions), hydrazine/oxime formation from aldehydes and ketones,
tetrazine ligation, isocyanide based click reactions, and quadricyclane ligations.73
Use of bioorthogonal reagents is generally done in a two-step process. First, the
biological host, such as cells or living organisms, is incubated with a reporter, a
metabolic precursor which contains a unique bioinert functional group. Then, the host is
treated with a probe that has a complimentary tag for bioorthogonality. These reactions
are second order, so the rates of reaction are dependent upon the concentrations of the
reactants and second order reaction kinetics.73

Figure 1.9: Cartoon of bioorthogonal targeting. In bioorthogonal chemistry, the cell is first
either targeted by a probe containing a functionalized group, or fed a functionalized
sugar (G1). This is then targeted by a reporter tag (G2) which contains either a
fluorophore or biotin. G1 and G2 covalently bond, leaving the cell covalently tagged.
1.3.1 Staudinger Ligation
The Staudinger ligation was developed by the Bertozzi lab at UC Berkley in
2000 as a modification to the Staudinger reduction for use with azides and
triarylphosphines.74 Strategic placement of an ester on the aryl substituent of the
phosphate allows for the formation of an amide bond via an intermediate aza-ylide.73
The Staudinger ligation has been particularly useful in biological imaging
experiments as fluorophores can be incorporated. This can be as simple as using a
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coumarin for the aryl ring 75 or installing a FRET quencher into the ester group. When
cleaved, the quencher can provide an alternate way for activation of fluorescence.76
The Staudinger ligation does have some issues with biocompatibility as azides
and phosphines have reactivity towards both thiols and disulfides. This can be mitigated
slightly by using TCEP, tris (2-carboxyethyl) phosphine, to reduce disulfides on the
surface of the protein.77 The Staudinger ligation suffers from slow reaction kinetics, and,
thus, excess amounts of triarylphosphine are needed to have the reaction go to
completion, causing issues when studying sensitive biological systems.78
1.3.2 Click Chemistry
The application of click chemistry in biology has been revolutionary in
determining the functions of different biomolecules that are not accessible by standard
antibody and genetic methods. Click reactions are those which are selective, high
yielding, have preferable reaction kinetics, simple to preform, and can be conducted in
benign solvents such as water. The term “click chemistry” was coined by Sharpless in
reference to the development of the copper-catalyzed [3+2] cycloaddition of an azide to
an acylic alkyne.79 Sharpless did not come up with the [3+2] cycloaddition, only
improved upon the chemistry that was discovered in the 1960’s by Huisgen.80 As such,
terminal azides have become the most popular functional group to add for
bioorthogonality as they are small in size and inert towards endogenous biological
functionalities.
Copper catalyzed click chemistry works well in most biological circumstances,
unless cell viability is needed. Copper is extremely toxic to living cells so there is a need
for copper free methods that retain the same fast reaction kinetics that are needed inside
the cellular environment. The Bertozzi lab has, once again, been one of the pioneering
labs in developing this technology by using molecules which contain a large amount of
ring strain, specifically cyclooctenes. Borrowing from president set by Huisgen 81,
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Wittig, and Krebol 82, Bertozzi used the information that cyclooctenes react explosively
with phenylazides and sought to lower the LUMO of the alkyne by withdrawing electron
density away from the triple bond. 83 Bertozzi’s group went on to synthesize difluronated
cylcooctene (DIFO), which has reaction kinetics similar to that of the copper catalyzed
click chemistry. Fluorophore functionalized versions of DIFO have since been
synthesized which allows for live imaging in cells, C.elegans, and zebrafish without the
worry of the toxic effects of copper.84
1.3.3 Activity Based Protein Profiling (ABPP)
One key development in the identification of protein interactions has been the
discovery and use of activity based protein profiling (ABPP). ABPP is used to visualize
the active form of any enzyme or protein by using chemical probes to tag it. The
prototype was first described in 1961 using a radioactive probe against esterases.85 This
technique was then refined by the Cravatt group at Scripts for use with enzymes using a
directed small molecule probe.86 Probes are directed towards an active site residue for
covalent attachment and then visualization can be achieved. These probes can be used to
detect proteins in a variety of complex biological environments including cell culture,
cell lysates, and even living cells.87
A typical activity based probe contains three parts: a targeted reactive group, or
warhead, a recognition element for selectivity, and some sort of detectable reagent. The
warhead is typically an electrophilic moiety that is used for covalent attachment to the
protein of interest. This electrophilic element needs to be reactive enough to quickly bind
to the protein of interest, yet should not be able to interact with offsite proteins. The
recognition element acts to direct the warhead to a willing nucleophile on the surface of
the protein. It also serves to be selective towards the targeted protein. The recognition
element is typically either a fluorophore, an affinity based tag, such as biotin, resin for
solid phase mass spec analysis, or some combination of all three. 87
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1.4 Conclusions
Taking everything into account that was presented in the introduction, it is clear
that what is sorely lacking is a small-molecule probe which can target towards, and
identify, calcium permeable AMPARs in situ. Use of this type of probe would allow for
identification of calcium permeable AMPARs in different neuronal subtypes and answer
questions about their inclusions during LTP. To do so, we need to design a probe that is
both specific and able to be used in a variety of cellular environments. We also need to be
able to incorporate a reporter tag, such as a fluorophore, so we can visualize the motion
of the AMPAR as it moves along the dendrite. This could have implications on how
signaling in LTP occurs through calcium permeable AMPARs and how calcium
permeable AMPARs are trafficked to the surface. This probe could also fill in some of
the gaps in LTP, such as AMPAR recycling.
A probe towards calcium permeable AMPARs could also lead to a better
understanding of why neurons switch between calcium-impermeable AMPARs and
calcium permeable AMPARs after traumatic brain events, such as ischemia, or
chemically induced trauma, such as addiction. If we are able to have a better grasp of
what is occurring, then better and more targeted treatments could be developed.
To do so, we designed nanoprobe 1 as a functionalized probe for the detection of
calcium permeable AMPARs. Subsequent testing with nanoprobe 1 showed that
nanoprobe 1is directed towards glutamate receptors, however we are not able to answer
questions about subtype. Nanoprobe 2 was then designed to more closely resemble the
natural polyamine antagonists of calcium permeable AMPARs, specifically
philanthotoxin-433. Nanoprobe 2 also could be used in a more refined method to answer
questions about subtype inclusion through pull-down experiments. However, nanoprobe
2 was not able to bind to any receptors. We then designed nanoprobe 3 off of the same
scaffold and added a more promiscuous electrophile, which could be activated using
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photochemistry. Ultimately, the same result was seen as with nanoprobe 2. We then
moved into new methods for bioorthogonal chemistry by using a two-step delivery
system. This new method does not rely on incorporation of an azide into the protein of
interest and will ultimately be further tested for ligand directed experiments.
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CHAPTER 1
NANOPROBE 1 AS A NEW METHOD FOR VISUALIZATION OF GLUTAMATE
RECEPTORS ON LIVE TARGETS
Portions of this chapter have been published as Vytla, D. et al. Org.Biomol. Chem. 2011, 9, pp.
7151-62 and Combs-Bachmann, R.E., et al. J. Neurochem. 2015 133(3), pp.320-29.
2.1 Introduction
AMPARs are the crucial glutamatergic neurotransmitters that are involved in
memory formation. They are discussed in detail in Section 1.1.8. In brief, they are
composed as tetrameric assemblies of GluA1-A4 subunits. AMPARs are calcium
permeable if they either lack the GluA2 subunit or contain an unedited form of GluA2.1
GluA2 undergoes a post-natal single RNA codon at what has been termed the Q/R site.
Here, the encoded glutamine is changed to an arginine via action of the enzyme ADAR.
(More about how this is exactly accomplished can be found in Section 1.1.9.) It is this
key change that mediates calcium permeability in AMPARs. Calcium permeable
AMPARs have very recently been shown to have a larger impact upon neuronal
development and in certain neuropathological diseases, such as ischemic injury and
ALS.2 Though the importance of calcium permeable AMPARs has been demonstrated,
methods to understand their exact abundance, expression patterns, and movements are
lacking.
In live neurons, methods to track these receptors, and other proteins, have
involved the delivery of a contrast agent to the receptor as either a small molecule
fluorophore or as a proteinaceous fluorophore. Proteinaceous fluorophores involve the
expression of either a fluorescent fusion protein or a small protein tag that is then targeted
by a fluorescent antibody.3 While these methods are exquisitely specific, they involve the
genetic manipulation of the receptor of interest or the delivery of a large protein to the
synaptic cleft. Genetic manipulation of iGluR subunits leads to formation of non-native
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homotetramers, due to the overexpression of the fluorescently encoded subunit. These
non-native homomers do not provide information about movement of the native system.3b
The synaptic cleft, or the space between the presynaptic and postsynaptic side of the two
neurons, is only about 20 nm in size.4 The application of an antibody to the synaptic cleft
targeted to the produced protein tag introduces a contrast agent that is similar in size to
the synaptic cleft, thus, will again not provide much useful information about trafficking
of the particular receptor of interest.5

Figure 2.1: Structure of nanoprobe 1. Nanoprobe 1 which contains spermine, an
open ion channel blocker (blue) as the targeting ligand, a ANI core (pink)
for photolysis, an acrylamide electrophile for bioconjugation to the
surface of the protein (red), and a Cy-3 fluorophore (green) for
visualization.
Taking the above into account, we decided to use the approach of delivering a
small molecule probe to covalently tag our receptor of interest. In order to have an
effective molecule for tagging native neuronal receptors, we must have a probe which is
small, non-perturbing, and will provide a contrast agent (in this case a fluorophore) for
visualization of the receptor. At its simplest, our probe design contains a photolabile core,
a targeting ligand, an electrophile for bioconjugation, and a fluorophore for visualization.
After probe application when we apply UV light to the system, the photolabile core is
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cleaved, removing the targeting ligand, thus leaving behind our receptor tagged with our
fluorophore for visualization via epifluorescence microscopy or confocal microscopy
(Figure 2.2). The probe needs to add the electrophile in a non-perturbing manor, so that
the receptor can function normally in order to fully understand how the receptor is
trafficking in a condition which leads to memory formation, such as LTP. In our first
version of this probe, termed nanoprobe 1, we used alkoxynitroindoline (ANI) caged
glutamate as our core, spermine as our targeting ligand, acrylamide as our electrophile,
and Cy-3 as our fluorophore.(Figure 2.1) 6 We chose spermine as our targeting ligand for
its known affinity for ionotropic glutamate receptors lacking GluA2 subunit, thus making
a good candidate for the detection of calcium permeable AMPARs due to its well
characterized use-dependency (discussed in Section 1.1.11).7

Figure 2.2: Cartoon of nanoprobe 1 mechanism. Glutamate (yellow dot) opens the
ion channel and is targeted by our spermine ligand (blue key) which allows
the acrylamide electrophile (red hook) to bind to nucleophile on the surface
of the receptor. Photolysis with UV light breaks the ANI core (pink box)
leaving the receptor tagged with the Cy-3 fluorophore (green star).
Reproduced from Vytla, D. et al. Org.Biomol. Chem. 2011, 9, pp. 7151-62
with permission from The Royal Society of Chemistry.
Tethered ligands have been used as a successful method of enhancing the local
reactivity of an electrophile proximal to a good nucleophile. This is due to the effective
local rise in concentration that comes after targeting ligand binds to its binding site, and
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then places the electrophile in proximity with a nucleophile on the surface of the protein
that is capable to undergo a Michael addition, such as a cysteine, serine, lysine, threonine,
or tyrosine. The effective concentration of the nucleophile rises approximately 100-1000
fold locally in the small space where the electrophile is captive in.6, 8
2.2 Results
2.2.1 Patch-Clamp Electrophysiology Confirms Use-Dependence of the Probe

Figure 2.3: Patch-clamp electrophysiology results from nanoprobe 1. A) Evoked glutamate
currents in HEK 293T cells transfected with GluA1 (L497Y)-pIRES2-eGFP. The evoked
current was taken first with 20 µM glutamate. Cells were incubated with 20 µM glutamate
and 1 µM nanoprobe 1 for 1 min and then the evoked current was re-measured. UV light
and glutamate were co-applied and the current was measured. A 60% blockage of current
was observed. The cells were washed for 1 min and the evoked glutamate current was
measured again, showing a return to the basal current. B) The same experiment was in A
was performed without the co-incubation with 20 µM glutamate. A slight block in the
evoked glutamate current was observed (~20%) without the co-incubation of glutamate
and nanoprobe 1. C) Quantification of the evoked glutamate current before and after UV
photolysis of the ANI core with co-incubation of glutamate (n=10) and without the coincubation of glutamate (n=6). Reproduced from Vytla, D. et al. Org.Biomol. Chem. 2011,
39 Royal Society of Chemistry.
9, pp. 7151-62 with permission from The

To confirm the use-dependence of the probe, we used patch-clamp
electrophysiology to measure the block of current evoked by applied glutamate and
adding in nanoprobe 1. AMPARs display an inwardly rectifying current and this is lost
upon biding of polyamines to the receptor. This loss of the current is also one of the key
ways to determine if the receptor is calcium permeable or calcium impermeable, as
calcium impermeable AMPARs are not sensitive to blocks by polyamine ligands; thus do
not exhibit current loss.9 We transiently transfected HEK-293T cells with GluA1
(L497Y)-pIRES2-eGFP homomultimers to create calcium permeable receptors in a
heterologous system. We then co-applied 20 µM glutamate with nanoprobe 1 and
measured the glutamate evoked current. The current decreased by approximately 60% to
that of an initial pulse of glutamate. This is consistent with data that has been collected by
others using other synthetic polyamines such as napthylacetylspermine (NAS).10 We then
applied UV light (380 nm) to the system to uncage the photolabile ANI core and applied
constant pulses of glutamate and we found that the evoked current returned back to
baseline glutamatergic signal. These experiments were repeated using 1µM nanoprobe 1
alone. What is found is there is only a slight blockage of the channel (~20%) and that
there was no UV-dependence on release of the spermine ligand. The slight pore blockage
may be due to the stochastic nature of AMPA receptors to open in the presentence of the
applied voltage.6, 10 This finding is graphically demonstrated in Figure 2.3.
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2.2.2 Live Cell Imaging of Dissociated Cultures of Hippocampal Neurons with Nanoprobe 1
Using Epifluorescence Microscopy
Next, we investigated the targeting capability of nanoprobe 1 towards
synaptically-active, polyamine-sensitive glutamate receptors in primary dissociated
hippocampal cell culture. Dissociated cultures of rat hippocampal neurons were prepared
and incubated to day in vitro (DIV) 20- 24. Neurons were first imaged using transmitted
light in order to determine areas were synaptically active neurons should reside. They
were then serially imaged using fluorescent light to acquire background data. Neurons
were then bathed with either spermine ligand lacking nanoprobe (where a carboxylic acid
is in place of the amide attached ligand) or nanoprobe 1 for 2 minutes in total darkness to
prevent premature photolysis of the ANI core. UV light (380 nm) was then applied to the
system and serial fluorescent imaging was then resumed. Extracellular buffer solution
was constantly perfused across the system throughout the experiment, with the exception
of the application of ligand lacking nanoprobe and nanoprobe 1. The Cy-3 fluorescence
that is observed is due to receptors being labeled in a use-dependent fashion with
nanoprobe 1. Fluorescence accumulation appears to be occurring in areas located at
synaptic regions, which is where active glutamatergic receptors are known to reside. We
can see from the bright-field image that these areas appear to contain synaptic spines,
which is where any synaptic activity would occur. (Figure 2.4) 6
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Figure 2.4: Representative images of neurons labeled with nanoprobe 1. A) Transmitted light
image of a neuron B) Fluorescence image of a neuron labeled with 750 nM of nonliganded nanoprobe 1 C) Fluorescence image of a neuron labeled with 750 nM nanoprobe
1 D) Time course of five ROIs (regions of interest) along a dendrite. The areas pointed out
with the arrows are 1 min after non-liganded nanoprobe and nanoprobe 1 application .E)
Fluorescence time course of the five ROIs (from D) during the course of the imaging
experiment displaying the prolonged fluorescence after the liganded application of the
probe. Reproduced from Vytla, D. et al. Org.Biomol. Chem. 2011, 9, pp. 7151-62 with
permission from The Royal Society of Chemistry.
When the ligand lacking probe is applied to the system, there is a slight increase
in fluorescence. This fluorescence is not persistent as it is quickly washed away when
perfusion is resumed. However, when nanoprobe 1 is applied to the same system, there is
persistence to the fluorescence accumulation that remains through the imaging event.
These results taken together suggest that nanoprobe 1 is acting in a ligand-dependent
manner and that we are achieving covalent attachment of the probe through a Michael
addition of the acrylamide to the biological nucleophile on the receptor surface.6
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2.2.3 Live Cell of Dissociated Cultures of Hippocampal Neurons with Nanoprobe 1 Using
Confocal Microscopy
We then wanted to further investigate the efficacy of our probe on neurons. We
first examined the dose dependency of our probe to find the optimal, minimal
concentration that can be used. Dissociated cultures of rat hippocampal neurons were
grown to DIV 14-17, as this is reported to be when cultured neurons are found to be
expressing synaptically active AMPARs.11 We explored a concentration range from 100
nM, 300 nM, 1 µM, and 3 µM of nanoprobe 1 to determine the lowest concentration that
would give us the best fluorescence accumulation. Imaging took place similar to that of
the epifluorescence imaging, with the major difference being the lack of constant
perfusion of fresh extracellular recording buffer being flowed across the neurons due to
technical limitations of the confocal microscope. Coverslips of neurons were removed
from their home media and washed three times with extracellular recording solution.
They were then imaged to collect the background fluorescence and then incubated with
20 µM glutamate along with the various concentrations of nanoprobe 1 in extracellular
buffer for 5 minutes in total darkness to prevent premature photolysis of the ANI core.
UV light was then applied to the system, and the coverslip was washed three times with
extracellular buffer. Neurons were then imaged to determine the fluorescence
accumulation on the cells. The same coverslip of neurons were used for each
concentration range to best determine the dose dependence of nanoprobe 1.11b
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Figure 2.5: Fluorescence accumulation with increasing amounts of nanoprobe 1.
Nanoprobe 1 was incubated with DIV 14-17 neurons along with 20µM glutamate.
Nanoprobe1 was used at 100 nM, 300 nM, 1µM, and 3µM to determine the lowest
working concentration to be used on cells with minimal background. The bar graph
quantifies fluorescence accumulation. Representative images are shown underneath.
Reproduced from Combs-Bachmann, R.E., et al. J. Neurochem. 2015 133(3),
pp.320-29with permission from John Wiley and Sons.

We found that our lowest concentration, 100 nM, did not provide significant
fluorescence over the background. However, the next highest concentration, 300 nM,
resulted in a marked increase of fluorescence over background and in areas that we had
seen in our epifluorescence imaging experiments. The brightest areas appeared to be on
that of synaptic spines, which was confirmed by examining the bright-field morphology.
(Figure 2.5) When the concentrations were increased to 1 µM and 3µM, the fluorescence
density at the areas described above was increased, but also increased amounts of nonspecific labeling of other structures. We determined that for all further imaging
experiments incubations of 20µM glutamate with 300 nM nanoprobe 1 would give us the
best fluorescence density with the lowest background.11b
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2.2.4 Competition Experiments of Nanoprobe 1 with Napthylacetylspermine and DNQX
We next wanted to determine the specificity of nanoprobe 1 against known
AMPAR antagonists. We chose napthylacetylspermine (NAS) and 6,7dinitroquinoxaline-2,3-dione (DNQX) as our antagonists. Nanoprobe 1 was designed to
act like NAS, so NAS was chosen to determine if the fluorescence we are seeing is due to
off-target reactions of nanoprobe 1 or if it is targeting the same channels as NAS. As
mentioned in the Section 1.1.9, NAS is used as a specific targeting moiety of calcium
permeable AMPARs and KARs over NMDARs.10 DNQX was chosen due it is known
activity to block the glutamate binding site on AMPARs and KARs, preventing the ion
channel from opening.

Figure 2.6: Dose-dependent labeling of nanoprobe 1 in competition with NAS and DNQX.
Nanoprobe 1 (300 nM) was dosed in competition with NAS (300 nM) or DNQX
(10µM). Fluorescence activity (shown in bar graphs) was decreased in the presence
of the antagonist and regained after subsequent dosing with nanoprobe 1.
Fluorescence was normalized to maximal accumulation. Representative images are
shown beneath bar graph. Reproduced from Combs-Bachmann, R.E., et al. J.
Neurochem. 2015 133(3), pp.320-29with permission from John Wiley and Sons.
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For our NAS experiments, dissociated cultures of rat hippocampal neurons were
grown to DIV 14-18. Cells were washed three times with extracellular buffer and were
then imaged to collect background fluorescence. They were then co-incubated with 300
nM NAS and 300 nM nanoprobe 1 in the presence of 20 µM glutamate for 5 minutes.
Cells were then washed three times with extracellular recording buffer and had UV light
applied to them for photolysis of the ANI cage. Fluorescent images were then collected.
The same set of cells were then washed and bathed in 300 nM nanoprobe 1 with 20 µM
glutamate for 5 minutes. Cells were washed three times in extracellular solution and then
fluorescent images were collected. Co-incubation of the neurons with NAS and
nanoprobe 1 lead to a slight increase in fluorescence over the background, however,
application of nanoprobe 1 alone lead to a large amount of fluorescence. This suggests
that NAS and nanoprobe 1 are in competition for the same binding site. (Figure 2.6)
For our DNQX experiments, co-applications of 10 µM DNQX and 300 nM
nanoprobe 1 and all imaging were carried out the same as for the NAS experiments. We
found that co-application of DNQX and nanoprobe 1 once again has a slight increase in
fluorescence compared to that of the background. The application of 300 nM nanoprobe
1 alone caused a large increase in fluorescence, suggesting that nanoprobe 1 is targeting
neurons that are sensitive to DNQX. Taken together, the NAS and DNQX co-application
data suggests that nanoprobe 1 is labeling neurons that may indeed be calcium permeable
AMPARs.11b
2.2.5 Fluorescence Gel with Nanoprobe 1
We wanted to confirm that we were indeed labeling calcium permeable
AMPARs with nanoprobe 1. To do so, we turned to SDS-PAGE analysis of nanoprobe 1
labeled neurons. Each AMPAR is composed of heterotetramers of GluA1-GluA4
subunits; the weight of each is ~ 100 kDa. Also, the density of AMPARs is varied across
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brain regions and neuronal subtypes. Knowing this, we chose to label the cortex, the
midbrain, and the cerebellum with two different concentrations of nanoprobe 1 in order to
pulldown subunits that would suggest calcium permeable AMPARs are being labeled.
Dissociated cultures of rat cortex, midbrain, and cerebellum were grown to DIV 18 in Tflasks. T-flasks were washed three times with extracellular buffer and then 300 nM or
3µM nanoprobe 1 along with 20 µM glutamate were applied for 5 minutes. Cells were
then washed three times with extracellular solution and lysed with a probe sonicator. The
cell lysates were then spun down and the cell pellet was re-suspended in PBS. The cell
lysates were separated on a 10% SDS-PAGE gel and fluorescence was measured using a
Typhoon gel scanner. Western blots were first run against a pan-AMPA antibody to
confirm that ionotropic glutamate subunits were present, then against GluA1 and GluA2
antibodies.

Figure 2.7: Fluorescence gel of nanoprobe 1 labeled neuronal proteins.
Cortex, mid-brain, and cerebellar neurons were grown to they were
synaptically active. Neurons were labeled with either 300 nM or 3
µM nanoprobe 1, lysed, and the proteins were separated on a 10%
SDS-PAGE gel. Fluorescence bands were measured using a
Typhoon 9210 flatbed imager. Fluorescence bands were measured at
the desired 100 kDa band, as well as 180, 85, 80, 60, 50, and 45 kDa.
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Our gel results show that we are indeed labeling a band that is around 100 kDa,
as well as many other bands (Figure 2.7).We are also labeling targets which are at 180,
85, 80, 60, 50, and 45 kDa. Nanoprobe 1 is based upon a class of polyamine toxins that
have been shown to display antagonism towards AMPARs, but there are other polyamine
sensitive targets, specifically acetylcholine receptors and KARs, that are be present in
primary culture. We cannot say if these are specific targets of the probe, or are just targets
which are reactive to the acrylamide electrophile on nanoprobe 1.
2.3 Discussion
Using a heterologous system of HEK 293T cells transfected with GluA1 L497Y
homomers and patch-clamp electrophysiology, we were able to determine that our probe
was indeed acting in a use-dependent fashion. Polyamine toxins have been used to target
towards active calcium permeable AMPARs as they will block the glutamate evoked
current that travels through the ion pore. This has been found with natural polyamine
toxins, such as Joro spider toxin and argiotoxin,9b, 12 as well as synthetic polyamines, such
as NAS.10 The IC50 of NAS is 0.33µM and blockage of calcium permeable AMPARs is
around 70%.10 This places our probe on par with NAS, however the IC50 of nanoprobe 1
would be extremely challenging, if not impossible, to determine as nanoprobe 1 does not
have a detectable off-rate.
In our initial imaging experiments, we targeted our probe to areas of known
pathology where synaptically-active, polyamine-sensitive glutamatergic neurons are
known to reside in dissociated cultures of rat hippocampal neurons. The distribution of
these receptors is heterologous between cultures and contains many other neuronal
receptor subtypes, specifically acetylcholine receptors. Our cultures also contain a very
large number of biological nucleophiles that could be potentially targeted by nanoprobe
1. Thus it is not impossible to imagine that we should have a large amount of

48

background reactivity of the probe towards these nucleophiles. However, nanoprobe 1 is
not just the acrylamide electrophile, rather a molecule that contains acrylamide as part of
its structure. Labeling of the targeted protein is only occurring once the effective
concentration of the probe and the acrylamide is achieved. This is clearly seen when
neurons are labeled with spermine lacking nanoprobe. We do not observe a large
accumulation of fluorescence anywhere, which would be expected if acrylamide was
having a large amount of off-target labeling.6
Our cultures also do not only contain active AMPARs, rather active glutamate
receptors. This means that we have both NMDARs and KARs present in culture. It is
possible that we are labeling both of these receptor subtypes as we are using a high
concentration of probe in our initial imaging experiments. Spermine can have activity
against NMDARs,13 however, much like how our probe is not simply acrylamide, our
probe is not simply spermine. Nanoprobe 1 was designed to resemble NAS, and NAS has
been used as a specific target towards calcium permeable AMPARs over NMDARs.10 We
can say that nanoprobe 1 is sensitive to non-NMDAR polyamine-sensitive glutamatergic
receptors.
Confocal imaging data of neurons labeled with nanoprobe 1 furthered our
understanding of where nanoprobe 1 is targeting. We first determined the lowest
concentration that we could use in imaging experiments in order to limit off-target
effects. The IC50 of polyamine toxins varies, but ranges from ~ 10 nM to 15 µM
depending on its intended target.14 Our probe falls into this scale, as 300 nM gave us the
best contrast. Once determined, our next goal was to determine the specificity of
nanoprobe 1. By using known AMPAR antagonists NAS and DNQX, we examined the
competition of nanoprobe 1 against them. What we found is that co-incubation with NAS
or DNQX prevents nanoprobe 1 binding, which is regained when nanoprobe 1 is
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reapplied alone. This suggests that nanoprobe 1 is indeed targeting towards receptors that
would appear to be calcium permeable AMPARs.
We then wanted to determine which receptors we were truly targeting. This was
done via SDS-PAGE analysis of three different regions of neurons labeled with
nanoprobe 1. What we found is that there is labeling something that could be an AMPAR
subunit, along with a variety of other unintended targets. This is certainly due to our
polyamine targeting ligand on nanoprobe 1, spermine, directing towards other polyamine
sensitive receptors, chiefly acetylcholine receptors. Our cultures come from a primary rat
source and contain a wide variety of receptor subtypes. These subtypes vary not only in
where they are located in the brain, but also from culture to culture. However, not all of
these receptors will be blocked by both NAS and DNQX as our imaging experiments
clearly show. Literature widely reports that both NAS and DNQX are antagonists
towards calcium permeable AMPARs, but they could not be as selective as reported.
Most of the early work in the literature is done in heterologous cultures in which
AMPAR subunits are present in high concentrations. There could very well be other
targets in neuronal culture that are polyamine sensitive that are yet to be identified. In
conclusion, nanoprobe 1 is a useful tool for the detection of active glutamate receptors in
dissociated culture of rat neurons, but questions about subtype inclusion in these tagged
receptors still need to be addressed.
2.4 Methods
2.4.1 HEK 293T Cell Culture
Cells were grown to they were 70 % confluent on cover glass (12mm, 1.0 size) in
DMEM media containing 10% FBS. Cells were grown at 6 % CO2 at 37°C. Cells were
transfected using LipoD293 (SignaGen Laboratories, Gaithersburg, MD, USA) with
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bicistronic vector GluA1 (L497Y)-pIRES2-eGFP 15 1-3 days before electrophysiological
experiments.
2.4.2 Dissociated Hippocampal Cell Culture
Primary dissociated hippocampal cell cultures were prepared from embryonic
day E18-20 Sprague-Dawley rat embryos and were cultured on polylysine-coated
coverglass (25.5 mm, 1.0 size for epifluorescence microscopy; 12mm 1.0 size for
confocal microscopy) in serum containing media identical to previous reports.16 Cells
were grown in 5% CO2 and at 37°C. All animal care and experimental protocols were
approved by the Animal Care and Use Committee at University of Massachusetts,
Amherst, Amherst, MA, USA.
2.4.3 Dissociated Cortex, Midbrain, and Cerebellar Cell Culture
Primary dissociated cortex, midbrain, and cerebellar cell cultures were prepared
from embryonic day E18-20 Sprague-Dawley rat embryos and were cultured on 25 cm2
T-Flasks coated in poly-lysine in serum containing media identical to previous reports.16
Cerebellar culture media was supplemented with 1M potassium chloride (1mL in 50
mL).17 Cells were grown in 5% CO2 and at 37°C. All animal care and experimental
protocols were approved by the Animal Care and Use Committee at University of
Massachusetts, Amherst, Amherst, MA, USA.
2.4.4 Live Cell Imaging with Nanoprobe 1 Using Epifluorescence Microscopy
Hippocampal neurons were imaged by excitation with a light from a Sutter
Lambda-LS illuminator (Sutter Instruments, Novato, CA,USA). A Nikon Eclipse Ti
series microscope (Nikon Corps, Tokyo, Japan) with a CFI Plan Apo VC 60X 1.4 NA oil
objective lens (Nikon) was employed for all imaging epifluorescence experiments. The
Cy-3 filter cue contained a 540/30 excitation filter, a 570 DRLP dichroic mirror, and 575
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ALP emission filter (all from Omega Optical Corp., Brattleboro, VT, USA). Images were
acquired using a Hamamatsu ORCA ER camera (Hamamatsu, Hamamatsu City, Japan)
and NIS Elements BR 3.1 software (Nikon Corps, Melville, NY, USA).
Cells were mounted in a 25 mm perfusion apparatus (ALA M-525, ALA
Scientific, Farmingdale, NY, USA) and bathed in extracellular buffer solution containing
138 mM NaCl, 1.5 mM KCl, 1.2 mM MgCl2, 5 mM HEPES, 2.5 mM CaCl2, and 14 mM
glucose at pH 7.4. Fresh recording buffer was constantly perfused over hippocampal
cultures using a perfusion device (ALA-UM8, ALA Scientific) at all times except for
nanoprobe 1 or ligand lacking nanoprobe were incubated. Fluorescence images were
acquired at 20 frames per second using the Cy-3 filter set to capture background and
post-labeled stopped leaving minimal buffer on cells. Next, 200 µL of 750 nM ligand
lacking nanoprobe was added to the bath and incubated for 2 minutes. Perfusion was
restarted and imaging was carried out for 10 minutes at which point the background
fluorescence was re-established and measured again for 1 minute. Perfusion was again
stopped, leaving minimal buffer on the cells. Finally, 200 µL of 750 nM nanoprobe 1
was added to the bath and incubated for 2 minutes. Perfusion was reinstated and imaging
was carried out for 10 minutes.
2.4.5 Image Analysis of Epifluorescence Imaging Data
Images were analyzed using ImageJ (U.S. National Institutes of Health,
Bethesda, MD, USA). Fluorescence was quantified using ROI (region of interest)
analysis of multiple regions placed over putative synaptic sites and areas of background.
The mean fluorescence intensity was background subtracted and normalized to the
measured fluorescence at 1 minute before the application of ligand lacking nanoprobe
and time courses were plotted using GraphPad Prism (La Jolla, CA, USA). Seven image
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series were analyzed and the data combined for a total of 131 ROIs analyzed. GraphPad
Prism was used to plot the data.
2.4.6 Live Cell Imaging with Nanoprobe 1 Using Confocal Microscopy
Hippocampal neurons were imaged using a Nikon TiE microscope fitted with a
CSU-x1 Yokogawa spinning disk confocal scan head (PerkinElmer, Waltham, MA,
USA) and an Andor iXon+ electron-multiplying CCD camera (Andor, Belfast, Northern
Ireland). All confocal settings were kept the same for the labeling experiments. The
microscope and lasers were controlled by MetaMorph software (Molecular Devices,
Sunnyvale, CA, USA). A 100x 1.4 NA objective (Nikon) was used for imaging. 250 ms
exposures of a 561 nm laser were used to image all fluorescence images, keeping
everything below pixel saturation. Pixel size is a 140 x 140 nm square.
Coverslips containing neurons were removed from their home media and
mounted into a 12 mm perfusion apparatus (Warner Instruments, P-3, RC-25, Warner
Instruments LLC, Hamden, CT, USA) and were bathed in extracellular recording buffer.
Coverslips were then washed three times and placed in a static bath of extracellular
solution. They were then imaged for 2 minutes to establish background fluorescence
levels. Testing solutions were then applied, either 20 µM glutamate with the ranging
nanoprobe 1 concentration, or the co-application of nanoprobe 1 with 10µM DNQX
(Tocris Bioscience, Bristol, United Kingdom) or 300 nM NAS (Sigma Aldrich St. Louis,
MO, USA), for 5 minutes in total darkness. Coverslips were irradiated with 405 nm light
for 15 seconds for photolysis of the ANI core. Coverslips were then washed three times
with extracellular solution and returned to a static bath. Imaging was then resumed.
2.4.7 Image Analysis of Confocal Imaging Data
All images were analyzed using ImageJ. To quantify fluorescence accumulation
of nanoprobe 1, areas of the field of view in which there was fluorescence activity after
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application of glutamate and nanoprobe 1 were identified by using the Triangle threshold,
in which the maximum of the histogram along a data linear data range is used as the
maximum threshold value.18 These threshold values were then used to generate a massive
ROI list of all labeled regions in the field. ROIs were then used at all previous time
points for quantification during the dosage and competition experiments. Fluorescence
intensities were quantified using the mean grey value of regions labeled with nanoprobe 1
and then background subtracted from the average of three ROIs drawn in areas where no
cells were present in the corresponding brightfield image. All brightness and contrast
was set equal in groups of comparative images for analysis. Group mean values at each
dosage or competition experiment were compared to the respective control values using a
one-way nonparameteric Kruskal-Wallis test. Significance values were assigned using a
Dunn’s multiple comparison test. In all cases, significance was determined to be p < 0.05
and p values are reported in all cases. Asterisks signify statically significance.
2.4.8 Fluorescent SDS-PAGE gel of nanoprobe 1 labeled neurons
25 cm2 T-Flasks were washed three times with extracellular buffer. 7 mL of 300
nM or 3 µM solutions of nanoprobe 1 in extracellular buffer with 20 µM glutamate were
added into the flasks and allowed to sit for 5 minutes at room temperature. Flasks were
then washed again three times with extracellular buffer. 2 mL of lysis solution, 1x PIC in
1x PBS buffer, were added to each flask and cells were then scraped into a 2 ml
Eppendorf tube. The cell lysates were then sonicated with a probe sonicator at 30%
power for 1 minute. A bicinchoninic acid (BCA) assay was run to ensure that same
amount of protein was added to each lane. Samples were run on a 10% SDS-PAGE gel
and sat for 16 hours in 10% acetic acid solution. The gel was imaged using a Typhoon
9210 flatbed imager using 532 laser line set using a 588 bandpass filter.
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2.4.9 Western Blots of Nanoprobe 1 Labeled Neurons
Using the same samples as the fluorescence gels and a BCA assay was run prior
to each blot. Protein lysate samples were run on 10% SDS-PAGE gels and transferred to
a nitrocellulose membrane using CAPS buffer for 16 hours at 4°C. Blots were first
probed with 1:200 Pan-AMPA (GluR-1/2/3/4) rabbit polyclonal antibody (Santa Cruz
Biotechnology Inc. Dallas, TX, USA). Subsequent blots were probed for GluA1
(Millipore, Billerica, MA, USA) and GluA2 (Millipore).
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CHAPTER 2
PHILANTHOTOXIN BASED PROBE FOR THE DETECTION OF CALCIUM
PERMEABLE AMPA RECEPTORS
3.1 Introduction
From our prior studies with nanoprobe 1, it is clear that we need to develop a
probe that could identify the proteins we were targeting. We also wanted to develop a
probe that could be easily synthesized and be used with a wide number of applications for
probing our receptors of interest. There are a wide number of polyamine toxins (Figure
1.7) that are used and modified to be used study calcium permeable AMPARs. Looking
at each of the polyamine toxins, the two main moeites of each are the aromatic head
group and the polyamine tail. We selected philanthotoxin-433 to move forward with as a
potential new probe for the detection of calcium permeable AMPARs for a number of
reasons, including its selectivity towards calcium permeable AMPARs and the ease of
modification.
Philanthotoxin-433 is the toxin in the venom of the parasitic wasp, Philanthus
triangulum, or the Egyptian digger wasp (also known as the European bee wolf). This
solitary wasp is generally an herbivore, but the pregnant wasp uses its venom to paralyze
its prey, honeybees, to leave for the larvae to eat.1 The venom of P. triangulum was show
by Piek and colleagues to be an antagonist of glutamatergic synapses in the motor
neurons of both locus leg muscle and honeybee muscle junctions.2 In 1988,
philanthotoxin was isolated from the venom via HPLC, its structure was determined, and
then pure toxin was synthesized. This molecule was named phlianthotoxin-433, with the
numbering referring to the number of methylene units contained in the polyamine tail.1
Derivatives of phlianthotoxin have since been synthesized, aiming to increase the
efficacy over the first isolated compound.3
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Nanoprobe 2 modifies philanthotoxin so that we can use it as a probe for the
detection of calcium permeable AMPARs. To do so, we added an electrophile for
bioconjugation onto the surface of the protein. We also installed an alkyne handle so that
our probe can be targeted and visualized with azido functionalized reporter tags that can
be attached using a 1,3-dipolar cycloaddition, or a click reaction.
We redesigned our nanoprobe to allow us to determine which receptors our probe
was targeting. One of the key reasons that we installed an alkyne handle onto nanoprobe
2, was to use our new probe in activity-based protein profiling experiments. Chemical
activity based protein profiling (described in Section 1.3.3 (chem ABPP)) was refined by
Benjamin Cravatt’s group, and involves a small molecule probe, equipped with an
alkyne, being directed towards a target of interest. Once the probe is covalently attached,
the protein can then be visualized using an azide functionalized reporter tag, usually a
fluorophore or biotin.4 The output can be visualized via SDS-PAGE analysis. Any bands
that are marked by the reporter tag can then be further analyzed by mass spectrometry. 4b
3.2 Results
3.2.1 Design of Nanoprobe 2
Nanoprobe 2 was designed to retain the key features of phlianthotoxin as much
as possible; unlike nanoprobe 1which was based on a synthetic analogue. To do so, we
eliminated the photoreactive core in nanoprobe 1 from the probe design of nanoprobe 2.
This was done for two main reasons. One was for the ease of synthesis of nanoprobe 2.
Nanoprobe 1 was completed in 26 steps, with the synthesis of the nitroindole core being a
portion of them. The second was to make a probe that was more representative of the
polyamine toxin class. We wanted to produce a probe that more closely resembled the
natural toxin, so that some of the off-target effects we were observing with nanoprobe 1
could be eliminated. We also wanted a probe that was a bit easier to use in the chemical
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ABPP experiments. Removal of the photolabile core also eliminates the photolysis step,
which simplifies its use. To the core structure of philanthotoxin-433, we amended the
butyl chain so it contains an electrophile, acrylamide, for bioconjugation to the surface of
the receptor. Much like nanoprobe 1, we are relying on proximity accelerated reactivity
to facilitate the Michael addition of the acrylamide to a nucleophile on the surface of the
protein. We also amended the phenolic hydroxide so that it contains an alkyne handle
than can be used for conjugation with an azide functionalized reporter tag.
Synthesis of nanoprobe 2 commenced with tyrosine. We then protected the
primary amine with Boc and the carboxylic acid with a methyl ester to install the alkyne
handle. Subsequent Boc deprotection allowed for the installation of nacrylaminohexanoic acid for the addition of the electrophile. We then deprotected the
carboxylic acid for peptide coupling with triBoc spermine. Boc deprotection afforded
nanoprobe 2, which contains spermine as our targeting ligand, much like nanoprobe 1.
(Scheme 3.1)
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3.2.2 Confocal Imaging of Cerebellar Neurons with Nanoprobe 2
We wanted to investigate if nanoprobe 2 was behaving similar to nanoprobe 1 in
dissociated cultures of neurons. We chose to use dissociated cultures of rat cerebellar
neurons in this case due to a reported higher concentration of calcium permeable
AMPARs.5 We first needed to make nanoprobe 2 amendable for visualization in live cell
imaging. To do this, we clicked on a fluorescent reporter tag, fluorescein (FAM-5) azide,
to nanoprobe 2. Since this click reaction is done through copper catalyzed methods, it
needed to be done prior to application to live cells to prevent the toxic effects of copper
on the neurons. Neuronal cultures were grown to DIV 18-20, washed three times with
extracellular recording solution, and mounted into a perfusion apparatus. They were then
covered in extracellular solution and imaged to collect background fluorescence data.
Nanoprobe 2 (10 µM) in extracellular solution was added to the neurons for 5 minutes at
room temperature. Neurons were then washed three times and imaged to collect
fluorescence.
Similar to what we observed with nanoprobe 1, nanoprobe 2 had fluorescence
accumulation that occurred in areas around synaptic regions that were seen in the
brightfield image. This suggests that nanoprobe 2 is targeting areas similar to nanoprobe
1. The fluorescence accumulation in these areas is greater than that of the background.
This is seen in Figure 3.2
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Figure 3.1: Confocal imaging of cerebellar neurons with nanoprobe 2. A) Transmitted
light image of cerebellar neurons B) Pre-probe application fluorescence image
C) Post-probe application fluorescence image D) Graph of fluorescence
accumulation in synaptic regions. Fluorescence is higher than the pre-probe
application. E) Overlay of post-probe fluorescence image with white light image
showing that fluorescence accumulation is in areas that are synaptically active.

3.2.3 Chemical Activity Based Protein Profiling on Dissociated Cultures of Rat Cortex, MidBrain, and Cerebellar Neurons
We then planned to investigate which ionotropic glutamate receptor subtypes we
are targeting with nanoprobe 2. To do so, 25 cm2 T-flasks of cortex, mid-brain, and
cerebellar neurons were grown to synaptically active (DIV 14-18). Flasks were washed
three times with extracellular recording buffer and then 0, 1, 3, or 10 µM of nanoprobe 2
dissolved in 7 mL of extracellular solution with 20 µM glutamate was applied for 5
minutes at room temperature. Control solutions containing equal concentration of
nanoprobe 2 and NAS were also made for additional flasks. Flasks were then washed
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three more times with extracellular solution. Next, 1 mL of lysis solution (1 x PIC, 1x
PBS) was added to each flask and cells were scrapped to remove from sides of the Tflask. Cells were lysed, and the membrane portions were spun down. The membrane
pellet was lysed again and the lysates were subjected to chemical activity based protein
profiling, chem ABPP. In chem ABPP, the azide functionalized reporter tag is added to
the lysate to undergo copper mediated click chemistry. The treated lysates were then
separated on a 10% SDS-PAGE gel.

Figure 3.2: In-gel fluorescence and Western blot of rat midbrain samples
labeled with nanoprobe 2. Top: Western blot of nanoprobe 2 labeled
midbrain samples conjugated with biotin azide. Samples were
separated on a 10 % SDS-PAGE gel, transferred to a nitrocellulose
membrane, and probed using streptavidin-HRP. Bottom: In-gel
fluorescence of nanoprobe 2 labeled midbrain samples conjugated
with rhodamine azide. Samples were separated on 10% SDS-PAGE
gel. In both cases, no signal was detected in probed neuronal samples.
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We used either rhodamine azide for fluorescence visualization or biotin azide for
Western blot analysis with streptavidin-HRP. The dual mode of visualization allows for
different levels of detection due to different sensitivities of each technique. The amount
of protein we are targeting amounts to only a very small portion of the total brain lysate.
After running both of these gels multiple times, we do not observe any signal in lanes
which contain brain lysate. (Figure 3.3)
3.2.4 Chemical Activity Based Protein Profiling with Cortex and Cerebellum Samples from
Female C57BL/6 Mice
After multiple trials with pre-natal dissociated culture, we then went to try
nanoprobe 2 in adult mouse brain samples because we were concerned that there was a
low concentration of our desired protein in our dissociated culture samples. Brain
samples were kindly provided by Jesse Mager’s lab in Veterinary and Animal Sciences at
UMass, Amherst. Brains were removed, segmented, and placed into extracellular
solution containing 20 µM glutamate and 0, 1, or 3 µM nanoprobe 2 or solutions
containing 20 µM glutamate with equimolar mixtures of nanoprobe 2 and NAS at the
same concentration as above. Brain samples were allowed to incubate in these solutions
for 15 minutes at room temperature and were then washed three times with extracellular
solution. Samples were then lysed using a probe sonicator and the lysates underwent
chem ABPP with biotin azide. Lysates were separated on a 10% SDS-PAGE gel,
transferred to a nitrocellulose membrane, and then probed using streptavidin-HRP. The
bands in this case were inconclusive (Figure 3.4), as biotin staining was present in control
samples which did not have any probe present. The cerebellum has a large amount of
endogenous biotin present in the mouse brain, the quantity is large enough that it can be
identified with streptavidin conjugated reporter tags.6
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Figure 3.3: Western Blot on C57BL/6 Cerebellum Samples. Cerebellum
samples were separated on a 10% SDS-PAGE gel, transferred to
nitrocellulose, and probed using StrepHRP (1:10000). There is strong
biotin staining in the 0 µM control lanes.
With this new information, we aliquoted 100µL of cell lysate to pre-clear with
streptavidin beads and run the supernate through the chem ABBP process. The supernate
was loaded onto a 10 % SDS-PAGE gel and a Western blot was done with streptavidinHRP. Again, there was strong labeling for biotin in the control lanes. (Figure 3.5) This
may be due to the amount of biotin present being higher than the capacity of the
NeutrAvidin beads.
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Figure 3.4: Western Blot on C57BL/6 Cerebellum Samples after NeutrAvidin preclearing. Cerebellum samples were first incubated using NeutrAvidin beads.
The supernatant was then separated on a 10% SDS-PAGE gel, transferred to
nitrocellulose, and probed using StrepHRP (1:10000). There is still strong biotin
staining in the 0 µM control lanes.

3.2.5 Chemical Activity Based Protein Profiling with Neurons from Protophormia
terraenovae
We decided to try a different approach in the testing of nanoprobe 2. Since
nanoprobe 2 is based on an AMPA receptor antagonist that has known activity in insects,
we decided to try to see if we could pull down targeted receptors in Protophormia
terraenovae, or the northern blowfly, (also known as the blue-bottle fly). (Gift from Dr.
John G. Stoffolano Jr., UMass, Amherst Plant, Soil, and Insect Science.) Flies were
anesthetized with chloroform and injected with 10 µL of 30µM nanoprobe 2. This
concentration is similar to that used in the locus and honeybee experiments performed by
Piek.2 Flies appeared to be paralyzed after injection with nanoprobe 2. They were then
were beheaded and the heads were placed in fly saline. The heads were then lysed using
a probe sonicator and the lysate was centrifuged to pellet exoskeleton. The supernatant
was removed and 75 µL was used for chem ABPP with rhodamine azide. Clicked lysate
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was run on a 12.5 % SDS-PAGE gel. Again, the gel did not show any fluorescence
bands. (Figure 3.6)

Figure 3.5: In-gel fluorescence of Protophormia terraenovae samples
labeled with nanoprobe 2. Protophormia terraenovae samples
were labeled with DMSO, nanoprobe 2, and SMII103. BSA
was run a control. No signal was seen in probe containing
samples.
3.3 Discussion
Nanoprobe 2 was designed to be a probe which could target calcium permeable
AMPARs and provide information about which subunits we were targeting, thus
identifying the subunit composition of this phenotype of receptors. Nanoprobe 2 was
designed from a philanthotoxin scaffold and an acrylamide electrophile was added for
bioconjugation to the surface of the targeted protein and an alkyne handle for “click”
conjugation to an azide functionalized reporter tag.
The synthesis of nanoprobe 2 that we designed was straightforward, however the
key peptide coupling step of triBoc spermine to compound 7 ((S)-2-(6acrylamidohexanamido)-3-(4-(prop-2-yn-1-yloxy) phenyl) propanoic acid) proved to be
more difficult than expected. The synthesis of triBoc spermine involves the protection of
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one of the primary amines with a trifluroacetatyl group, then the protection of the
remaining primary amine with Boc, then the deprotection of the ethyl trifluroacetate
group, and finally a column clean up step. (Scheme 3.2) The column clean-up is run with
ammonia containing running solution and detection of the molecule is done by ninhydrin
staining, as there are no easily detectable UV active moieties on the molecule.7 The
highest yield reported for this sequence of synthetic steps is 50%, 7-8 thus there is a large
amount of heterogeneity from batch to batch of triBoc spermine due to the difficult
purification that is required. This heterogeneity could be leading to some of the issues
that come in the peptide coupling experiment. Also, the peptide coupling reaction
between the carboxylic acid on compound 7 and the primary amine on triBoc spermine
proceeds slowly and to only 55% completion. Attempts were made to speed up the
reaction by making an activated ester of the carboxylic acid, but these efforts were futile
as it only seemed to impair the reaction even further. Multiple peptide coupling
conditions were attempted before choosing diisopropylcarbodiimide as our peptide
coupling reagent.

Scheme 3.2: Synthesis of triBoc spermine

In imaging experiments with dissociated cultures of rat cerebellar neurons,
nanoprobe 2 appears to be behaving similar to that of nanoprobe 1. Fluorescence
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accumulation was observed in areas where synaptic regions are present in the bright field
image. This indicates that nanoprobe 2 is binding to similar areas to that of nanoprobe 1.
Nanoprobe 2 was designed to be a probe to be better targeted towards calcium permeable
AMPARs, so it was encouraging that the fluorescence activity is similar to that of
nanoprobe 1. Also, it is encouraging that the modifications that were made to the
philanthotoxin structure did not disrupt the binding of the probe. As stated in Section
1.1.11, polyamine toxins target the open ion pore with the polyamine tail biding inside
the ion channel and having the aromatic head act as a steric mass that prevents full
passage though the ion conduction pore. The main modifications to the philanthotoxin
structure were made to regions on the aromatic head (see Scheme 3.1), so binding into
the pore should not be disrupted. Further study with AMPAR antagonists would
conclusively determine if we are indeed targeting receptors that may be calcium
permeable AMPARs.
We then assayed whole brain lysates for ionotropic glutamate receptor
identification with chem ABPP in three variant species, dissociated cultures of embryonic
rat neurons, sectioned brain samples of adult female mice, and neurons from
Protophormia terraenovae. All of these have known populations of receptors that are
sensitive to polyamine toxins. We applied nanoprobe 2 to these samples, lysed the
protein, and then separated the lysate on SDS-PAGE gels. With the dissociated culture of
embryonic rat neurons, we did not find any bands on the gel using either in-gel
fluorescence or Western blot analysis. This analysis was performed on cultured cortex,
midbrain, and cerebellar neurons. We hypothesized this may be due to the overall low
expression of calcium permeable AMPARs. Since the protein samples are from a
primary source, there are myriad other proteins in the samples. Also, the amount of
receptors is variable from culture to culture. So with a low amount of native protein
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available, it is plausible that we could be labeling something but simply not able to detect
the signal.
We then decided to use mature brain samples from C57BL/6 female mice.
Samples of the cortex and the cerebellum were removed, treated with nanoprobe 2, and
lysed with a probe sonicator. The first set of gels was probed against streptavidin-HRP.
Unfortunately, our first set of experiments resulted in positively labeled bands in the nonlabeled (0 µM probe) lanes in the areas where we would expect to see ionotropic
glutamate receptors. The cerebellum has a large amount of endogenous biotin present.6
Biotin is present in many tissues as it is a required cofactor in oxidative metabolism for
carboxylases; thus is heterogeneously distributed throughout tissues in the body. In
neurons, here is expression of biotinidase (a biotin recycling enzyme), and there is also
the presence of active carrier-mediated biotin transport mechanisms. All of these add to
the endogenous amount of biotin that is present in the brain.6 We tried adding
NeutrAvidin beads into the lysate prior to the click reaction with azido biotin in an
attempt to pre-clear any biotinylated proteins. This was only marginally successful as
subsequent gels still contained positive biotin bands in the control lanes, albeit less than
that of the original.

Figure 3.6: ClustalW alignment of GluA2 isoforms. ClustalW alignment of the M2
transmembrane domain of mouse, rat, human, and drosophila. The Q/R site is
highlighted in blue and is conserved through species.
We decided to take a step back from the complex networks of the mammalian
brain and see if nanoprobe 2 would work as an antagonist in insects as the glutamate
receptor is reported in insects (Figure 3.6). We obtained Protophormia terraenovae, a
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large fly species, for these experiments. We first injected nanoprobe 2 into the abdomen
of the flies and observed the behavior of the fly. Flies showed lethargic effects including
paralysis of wings, staggered walking, and slowed reaction to noise stimulus. This was
not present in flies injected with a DMSO control. Flies were then beheaded to analyze
their main neurons. The lysates underwent click chemistry with FAM-5 azide and SDSPAGE gels were run. Again, these results were inconclusive as the fluorescence gels
showed no bands, however coomassie staining showed the presence of protein. This
suggested to us that nanoprobe 2 is not covalently binding to the receptor of interest.
These results from all of the gel experiments taken together suggest that
nanoprobe 2 is not covalently modifying the target protein (or other proteins). We made
major changes to the structure of nanoprobe 1 in the design of nanoprobe 2, the largest
being the removal of the photolabile core to a phenolic one. This changed the position of
the points of attachment for the ligands on nanoprobe 2 over nanoprobe 1. Likely the
most important difference between the two molecules is the distance between the
polyamine ligand and the targeting electrophile. In nanoprobe 2 this distance is much
shorter, thus the electrophile is not exploring the same protein space as nanoprobe 1.
Attachment to the receptor of interest involves the Michael addition of our acrylamide
electrophile to a biological nucleophile on the surface of the receptor. If there is not a
suitable partner, then the covalent attachment will not occur. The binding pocket of the
AMPA receptor is quite greasy, composed of proline, isoleucine, and threonine,9 so it is
quite possible that there are simply no competent nucleophiles present in the area of our
electrophile. Without this covalent attachment, the receptor is not tagged, thus any
subsequent experiments into identification would lead to the non-result that we have
observed.
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3.4 Methods
3.4.1 General Information
All reagents were purchased through Fisher Scientific (Fair Lawn, NJ, USA)
unless otherwise noted. FAM-5 azide was purchased from Lumiprobe (Hallendale Beach,
FL, USA). All moisture sensitive reactions were done under an argon atmosphere using a
syringe-septum cap technique. Dry dimethylformamide (DMF) and acetonitrile (MeCN)
were purchased from Sigma Aldrich (St. Louis, MO, USA). Analytical thin layer
chromatography (TLC) was carried out on Merck Silica gel 60 F254 glass plates and
visualized using UV light (254 nm), ninhydrin, or bromocrestol green staining. Sorbent
Technologies (Atlanta, GA, USA) silica gel (230-450 mesh) was used for flash
chromatography. 1H NMR and 13C NMR spectra were collected on a 400 MHz Bruker
NMR spectrometer using the residual proton or carbon resonance of the solvent as the
standard. Chemical shifts are reported in parts per million (ppm). The following
abbreviations are used for peak multiplicities: s, singlet; d, doublet; dd, doublet of
doublets; t, triplet; m, multiplet. Mass spectra were measured using either a Waters ZQ
for LCMS, or at the UMass Mass Spec facility for HRMS, UMass Amherst.
3.4.2 Synthesis of Nanoprobe 2
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Methyl Ester Protection of Tyrosine (1)
Acetyl chloride (15 mL, 210.9 mmol) was added slowly to methanol (110 mL)
while stirring vigorously. Tyrosine (5.59g, 30.6 mmol) was added and the solution was
heated to reflux for 18 hours. The solution was cooled to room temperature and the
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solvent was removed in vacuo. (5.04 g, 94 % yield). The product matched literature
spectra and was used without further purification.10
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Boc Protection of Tyrosine Methyl Ester (2)
Compound 1 (5.04 g, 25.8 mmol) was dissolved in absolute ethanol (110 mL).
Sodium bicarbonate (22.52 g, 268.1 mmol) and di-tert-butyl dicarbonate (8.42 g, 38.6
mmol) were added and the reaction was stirred at room temperature for 24 hours. The
reaction was passed through a fritted funnel to remove sodium bicarbonate and the
solvent was removed in vacuo. The resulting white solid was spectroscopically identical
to literature and was used without further purification. (6.53 g, 90%.) 10
O
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HN

HO
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C3H3Br
K2CO3, DMF

O
3

O

O
O
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O

Methyl 2-( (tert-butoxycarbonyl) amino)-3-(4-(prop-2-yn-1-yloxy)
phenyl)propanoate (3)
Compound 2 (5.00 g, 16.9 mmol) was dissolved in dry DMF (100 mL).
Anhydrous potassium carbonate (7.05 g, 51.0 mmol) was added and the reaction mixture
stirred for 30 min at 0°C. Propargyl bromide (80% solution in toluene, 3.02 g, 25.4
mmol) of was added dropwise and the reaction mixture was allowed to warm to room
temperature with stirring for 18 hours. The reaction was then quenched with deionized
water (100 mL) and extracted using ethyl acetate (3x 20 mL). The solvent was removed
in vacuo. The resulting yellow oil was spectroscopically identical to literature and was
used without further purification. (4.43g, 67% yield) 11
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(S)-Methyl 2 amino-3-(4-(prop-2-yn-1-yloxy)phenyl)propanoate(4)
Compound 3 (2.83 g) was deprotected using 1M anhydrous hydrochloric acid (50
mL). The reaction mixture was stirred for 4 hours and hexanes (10 mL) was added to
precipitate the HCl salt of the desired product. A solid white precipitate was filtered,
dried, and was used without further purification as it was spectroscopically identical to
literature. (1.28 g, 49%)11
O

H
N

HO

O

6-Acrylamidohexanoic acid (5)
Hexanoic acid (5.17 g, 39.4 mmol) was combined with calcium hydroxide (5.34
g, 44.5 mmol) in deionized water (70 mL). A catalytic amount of hydroquione (1 mg, 9
mmol) was added and the reaction stirred at 0°C for 20 min. Acryolyl chloride (3.6 ml,
44.51 mmol) was added dropwise and the reaction mixture was stirred at 0°C for an
additional 15 minutes on ice. Conc. hydrochloric acid (6 mL) was added drop wise until
the product precipitated out. The resulting pale brown solid was spectroscopically
identical to literature and was used without further purification. (2.76 g, 67% yield) 12
O

O
HO
O
O

NH2
4

H
N

O
O

EDC, HOBt, DIPEA
4:1 ACN:DMF

5

O
NH

O
6

O

H
N
O

(S)-Methyl 2-(6-acrylamidohexanamido)-3-(4-(prop-2-yn-1yloxy)phenyl)proanoate (6)
Compound 5 (1.52 g, 8.24 mmol) was combined with 1-ethyl-3-(3dimethylaminopropyl)carbodiimide (1.39 g ,7.24mmol) and hydroxybenzyltriazole (1.11
g ,7.18 mmol) in 4:1 acetonitrile:DMF (15 mL). This solution was stirred for 10 minutes,
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then N,N-diisopropylethylamine (9.55 mL, 54.9 mmol) was added. The reaction mixture
was stirred for an additional 30 minutes, and then compound 4 (1.28 g, 5.84 mmol) was
added and stirred overnight at room temperature. The reaction underwent an extraction
with 3x10 mL of 1 M hydrochloric acid and 3x10 ml of 1M sodium chloride into
dichloromethane and was dried over sodium sulfate to leave a white solid. (334 mg, 17%)
1

H NMR (400MHz , CDCl3) δ = 7.02 (d, J = 8.3 Hz, 2 H), 6.88 (d, J = 8.6 Hz, 2 H), 6.23

(s, 1 H), 6.27 (s, 1 H), 6.16 - 6.05 (m, 2 H), 5.58 (d, J = 10.1 Hz, 1 H), 4.80 (q, J = 6.3
Hz, 1 H), 4.64 (s, 2 H), 3.70 (s, 3 H), 3.37 - 3.22 (m, 2 H), 3.07 (dd, J = 5.6, 14.1 Hz, 1
H), 2.99 (dd, J = 6.3, 13.9 Hz, 1 H), 2.56 - 2.50 (m, 1 H), 2.16 (t, J = 7.2 Hz, 2 H), 1.64 1.44 (m, 5 H), 1.37 - 1.21 (m, 3 H), 1.21 - 1.04 (m, 1 H).

C NMR (101MHz , CDCl3) δ

13

= 172.2, 171.9, 165.3, 156.3, 130.7, 129.8, 128.5, 125.7, 114.6, 78.1, 76.7, 76.4, 75.2,
55.4, 52.7, 51.9, 38.7, 36.5, 35.6, 28.5, 25.8, 24.4 LCMS (M/Z = 401.1), HRMS
C22H28N2O5; calculated (M +Na)+= 423.1890; observed (M + Na 423. 1892)+
O

O
O
NH

O
6

O

H
N

LiOH
1:1 THF:H2O

OH
NH

O
7

O

H
N
O

O

2-(6-acrylamidohexanamido)-3-(4-(prop-2-yn-1-yloxy)phenyl)propanoic acid(7)
Compound 6 (334.4 mg, 0.835 mmol) was dissolved in 1:1 THF: water (4 mL)
and stirred at 0°C for 20 minutes. Lithium hydroxide (214.6 mg, 5.11 mmol) was added
and the reaction mixture was stirred for 3 hours. The reaction was quenched with 3M
hydrochloric acid until pH equal to 1 on pH paper. The resulting solution was extracted
with ethyl acetate and dried over magnesium sulfate. The solvent was evaporated in
vacuo. (214 mg, 66 %). 1H NMR (400MHz ,Methanol-D4) δ = 7.20 - 7.14 (m, J = 8.6 Hz,
2 H), 6.96 - 6.86 (m, J = 8.6 Hz, 2 H), 6.31 - 6.15 (m, 2 H), 5.65 (dd, J = 3.7, 8.2 Hz, 1
H), 4.70 (d, J = 2.3 Hz, 2 H), 4.65 (dd, J = 4.9, 9.5 Hz, 1 H), 3.26 - 3.19 (m, 2 H), 3.16
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(d, J = 4.8 Hz, 1 H), 2.96 - 2.85 (m, 2 H), 2.19 (t, J = 7.3 Hz, 2 H), 1.60 - 1.44 (m, 4 H),
1.32 - 1.17 (m, 2 H) 13C NMR (101MHz ,Methanol-D4) δ = 174.5, 173.5, 166.7, 156.8,
130.8, 129.8, 125.0, 114.6, 78.5, 75.3, 55.2, 53.8, 47.6, 38.8, 36.2, 35.2. LCMS
(M+H=384.4); HRMS C21H26N2O5 calculated (M + Na)+=409.1734; observed (M+ Na)+
= 410.1781)
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Tert-butyl (4-((3-aminopropyl)(tert-butoxycarbonyl)amino)butyl)(2-(((tertbutoxycarbonyl)amino)ethyl)carbamate (8)
Spermine (1.61g, 7.95 mmol) was dissolved in methanol (40 mL) and cooled to 78°C using an acetone/dry ice bath for 20 minutes. Ethyltrifluoroacetate (1.35 mL,
1.12g) was added dropwise and reaction stirred at -78°C for 1 hour. The reaction was
then warmed to 0°C for one hour before addition of di-tert-butyl dicarbonate (6.85 g,
31.3g). The reaction mixture was warmed to room temperature and stirred overnight.
Conc. ammonia was added dropwise until the pH equaled 11 on pH paper, and the
reaction was stirred an additional 18 hours. The solvent was then evaporated in vaccuo
and a flash column was run using 70:10:1 CH2Cl2:CH3OH:ammonia to 50:10:1
CH2Cl2:CH3OH:ammonia gradient as the mobile phase. The resulting pale yellow oil was
spectroscopically identical to literature. (543 mg, 13.5 %) 7
O
OH
NH

O
7

O

Boc
N

O
TriBoc spermine 8
DIC 4:1 ACN:DMF
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(S)-tert-butyl (3-(2-(6-acrylamidohexanamido)-3-(4-(prop-2-ynyloxy)phenyl)propanamido)propyl) (4-((tert-butoxycarbonyl)(3-((tertbutoxycarbonyl)amino)propyl)amino)butyl)carbamate (9)
Compound 7 (149.8 mg, 0.3876 mmol) was dissolved in 4:1 acetonitrile:DMF (2
mL) and then added N,N-diisoproylcarbodiimide (127.2 mg, 157.9 uL, 1.00 mmol) and
diisopropylethylamine (cat.). The reaction mixture was stirred for 20 minutes, and then
compound 8 (676.2 mg, 1.34 mmol.) dissolved in DMF (2 mL) was added. The reaction
mixture was stirred overnight and then extracted into ether (40 mL); the reaction mixture
was washed with 1 N HCl (3x20 mL) and 1 N NaOH (3x 20 mL) and dried over
magnesium sulfate. The solvent was removed in vacuo. and the resulting residue was
purified via preparative HPLC (minutes 1-5 75% water, 25% acetonitrile; minute 5-35
5% water, 95% acetonitrile) (70 mg, 21%)) 1H NMR (400MHz ,CDCl3) d = 7.19 - 7.12
(m, J = 8.6 Hz, 2 H), 6.96 - 6.87 (m, J = 8.3 Hz, 2 H), 6.30 (dd, J = 1.5, 16.9 Hz, 1 H),
6.13 (dd, J = 10.4, 16.9 Hz, 1 H), 5.64 (dd, J = 1.4, 10.2 Hz, 1 H), 4.68 (d, J = 2.3 Hz, 2
H), 3.33 (d, J = 6.1 Hz, 4 H), 3.33 (d, J = 19.7 Hz, 2 H), 3.23 - 3.01 (m, 9 H), 2.54 (t, J =
2.3 Hz, 1 H), 2.22 (d, J = 6.8 Hz, 2 H), 1.73 (br. s., 2 H), 1.66 - 1.60 (m, 4 H), 1.54 (br. s.,
2 H), 1.48 (s, 13 H), 1.44 (s, 9 H), 1.36 - 1.27 (m, 2 H). LCMS (M+H) = 871.11
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(S)-6-acrylamido-N-(1-((3-((4-((3-aminopropyl)
amino)butyl)amino)propyl)amino)-1-oxo-3-(4-(prop-2-yn-1-yloxy)phenyl-2yl)hexanamide (10)
Compound 9 (70 mg, 0.12 mmol) was deprotected using 3M anhydrous
hydrochloric acid (2 mL) in ethanol. The reaction stirred for 18 hours and was
precipitated as the HCl salt using hexanes (1 mL). (9.8 mg, 14%) LCMS (M+H=571.6)
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(S)-Tert-butyl (3-(2-(6-acrylamidohexanamido)-3-(4-((4-(2-(3',6'-dihydroxy-3-oxo3H-spiro[isobenzofuran-1,9'-xanthen]-6-ylcarboxamido)ethyl)-1H-1,2,3triazol-1-yl)methoxy)phenyl)propanamido)propyl)(4-((tertbutoxycarbonyl)(3-((tertbutoxycarbonyl)amino)propyl)amino)butyl)carbamate(11)
Compound 9(27 mg, 0.031 mmol) was combined with 10uL of 10 mM stock
FAM-5 azide in DMSO, 5% copper sulfate pentahydrate (0.032 mmol) dissolved in
water, and 10% sodium ascorbate (0.0313 mmol) dissolved in water and was stirred for
48 hours. The resulting solution was extracted into CH2Cl2 and the solvent was removed
in vacuo. (9.7 mg, 1%) LCMS= 1329.19.
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(S)-N-(2-(1-((4-(2-(6-acrylamidohexanamido)-3-((3-((4-((3aminopropyl)amino)butyl)amino)propyl)amino)-3oxopropyl)phenoxy)methyl)-1H-1,2,3-triazol-4-yl)ethyl)-3',6'-dihydroxy-3oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-6-carboxamide (12):
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Compound 11 (9.7 mg, 0.001 mmol) was deprotected using 3M anhydrous
hydrochloric acid (2 mL) in ethanol. The reaction stirred for 18 hours and was
precipitated as the HCl salt using hexanes (1 mL). (3.1 mg, 5%) LCMS= 1028.19
3.4.3 Dissociated Cerebellar Cell Culture
Primary dissociated cerebellar cell cultures were prepared from embryonic day
E18-19 Sprague-Dawley rat embryos and were cultured on polylysine-coated coverglass
(12mm, 1.0 size) in serum-containing media identical to previous reports.13 Cells were
grown in 5% CO2 at 37°C. All animal care and experimental protocols were approved by
the Animal Care and Use Committee at the University of Massachusetts Amherst,
Amherst, MA, USA.
3.4.4 Dissociated Cortex, Midbrain, and Cerebellar Cell Culture
Primary dissociated cortex, midbrain, and cerebellar cell cultures were prepared
from embryonic day E18-20 Sprague-Dawley rat embryos and were cultured on 25 cm2
T-Flasks coated in poly-lysine in serum containing media identical to previous reports.14
Cerebellar culture media was supplemented with 1M potassium chloride (1 mL in 50 mL
of total media)13 Cells were grown in 5% CO2 and at 37°C. All animal care and
experimental protocols were approved by the Animal Care and Use Committee at
University of Massachusetts, Amherst, Amherst, MA, USA.
3.4.5 Live Cell Imaging with Nanoprobe 2
Cells were imaged using a 488 nm laser line on a Yokogawa Spinning Disc
Confocal (Tokyo, Japan) on a Nikon Eclipse Ti series microscope (Nikon Corps Tokyo,
Japan) with a CFI Plan Apo VC 100x 1.4 NA oil objective lens (Nikon) was used for
imaging experiments. Images were acquired using an Andor cooled EMCCD camera
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(Andor Technology Belfast, UK) and MetaMorph software (Molecular Devices
Sunnyvale, CA USA).
Cells were removed from their home media and washed three times in
extracellular buffer solution (138 mM NaCl, 1.5 mM KCl, 1.2 mM MgCl2, 5 mM
HEPES, 2.5 mM CaCl2, and 14 mM glucose at pH 7.4). They were then placed into a
static bath of extracellular solution and imaged for a minute to collect the background
fluorescence. 2 µM nanoprobe 2 was added to the bath for 5 minutes at room
temperature and cells were washed three more times with extracellular solution. Cells
were then imaged for 5 minutes to collect fluorescent data.
3.4.6 Image Analysis of Confocal Imaging Data
Images were analyzed using ImageJ (U.S. National Institutes of Health,
Bethesda, MD, USA). Fluorescence was quantified using ROI (region of interest)
analysis of multiple regions placed over putative synaptic sites and areas of background.
The mean fluorescence intensity was background subtracted and fluorescence intensities
were plotted using GraphPad Prism (La Jolla, CA, USA). Two image series were
analyzed and the data combined for a total of 118 ROIs analyzed.
3.4.7 Chemical Activity Based Protein Profiling on Dissociated Cultures of Rat Cortex,
Midbrain, and Cortex Neurons
25 cm2 T-flasks of cortex, mid-brain, and cerebellar neurons were grown to they
were synaptically active (DIV 14-18). Flasks were washed three times with extracellular
recording buffer. 0, 1, 3, or 10 µM of nanoprobe 2 dissolved in 7 mL of extracellular
solution with 20 µM glutamate was applied for 5 minutes at room temperature. Control
solutions containing equimolar concentrations of nanoprobe 2 and NAS were also made
for additional flasks. Flasks were then washed three more times with extracellular
solution. 1 ml of lysis solution (1 x PIC, 1x PBS) was added to each flask and cells were
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scrapped to remove from sides of the T-flask. Cells were lysed with a probe sonicator
30% power for 1 minute, and the membrane portions were spun down. The membrane
pellet was lysed again using the same conditions and a BCA assay was run to quantitate
protein concentrations. Master mixes for click solutions were prepared with 1 mM
CuSO4*5H2O (50 mM stock), 100 µM THPTA (1.7 mM stock), and freshly prepared 1
mM TCEP (50 mM stock). These incubated for 10 minutes and 10 µM of either
rhodamine azide or biotin azide were then added. A separate control master mix was
prepared by substituting deionized water in for the CuSO4*5H2O. 50 µL of cell lysate
were removed and the appropriate master mix was added to the tube with the reaction
going for one hour. Samples were then separated on a 10% SDS-PAGE gel. For in-gel
fluorescence experiments, gels were placed into 10% acetic acid for a minimum of 10
mintures and imaged using a Typhoon imager. For Western blot experiments, proteins
were transferred to a nitrocellulose membrane and probed against streptavidin HRP
(1:10,000) (Thermo Scientific, Waltham, MA, USA). HRP was activated using Super
Substrate West Pico Chemiluminescent substrate (Thermo Scientific).
Chemiluminescence was measured using a PxSys imaging system.
3.4.8 Chemical Activity Based Protein Profiling of Cortex and Cerebellum Samples from
C57BL/6 Female Mice
Brain samples were kindly provided by Jesse Mager’s lab in Veterinary and
Animal Sciences at UMass, Amherst. Brain samples were removed after cervical
dislocation of the mice and placed into extracellular solution containing 20 µM glutamate
and 0, 1, or 3 µM nanoprobe 2 or solutions containing 20 µM glutamate with equimolar
mixtures of nanoprobe 2 and NAS at the same concentration as above. Brain samples
were allowed to incubate in these solutions for 15 minutes and were then washed three
times with extracellular solution. Samples were then lysed using a probe sonicator and
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underwent chem ABPP with biotin azide similar to Section 3.4.7. Lysates were separated
on a 10% SDS-PAGE gel and then probed using streptavidin-HRP.
100µL of cell lysate to pre-clear with streptavidin beads (NeutrAvidin agrose
resin, Thermo Scientific) and run the supernate through the chem ABPP process. The
supernate was loaded onto a 10 % SDS-PAGE gel, separated, and transferred to a
nitrocellulose membrane. Western blots were done against streptavidin-HRP. HRP was
detected using SuperSignal West Pico Chemiluminescent subtrate, and imaged using the
PxSys imaging system.
3.4.9 Chemical Activity Based Protein Profiling on Neurons from Protophormia terraenovae
Protophormia terraenovae were a gift from Dr. John G. Stoffolano Jr., UMass,
Amherst Plant, Soil, and Insect Science. P. terraenovae were obtained at their young
adult stage and kept in a cage with sugar water. Flies were removed from their
confinement with a 50 mL Falcon tube, anesthetized with chloroform, and injected with
10 µL of 30µM nanoprobe 2 or DMSO with a 27.5 G needle into the thorax. Flies were
beheaded and the heads were placed in fly saline (140 mM NaCl, 5.0 mM KCl, 7.0 mM
CaCl2*2H2O, 1.0 mM MgCl2*6H2O, 5.0 mM TES, 4.0 mM NaHCO3, 5.5 mM trehalose,
and 9.4 mM sucrose, pH= 6.9). The heads were then lysed using a probe sonicator and
the lysate was centrifuged to pellet exoskeleton. The supernatant was removed and 75
µL was used for chem ABPP with FAM-5 azide. Tagged lysate was separated on a 12.5
% SDS-PAGE gel. In-gel fluorescence was measured using a Typhoon 9210 imager.
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CHAPTER 3
PHOTOCHEMCIAL PHLIANTHOTOXIN BASED PROBE FOR THE DETECTION OF
CALCIUM PERMEABLE AMPA RECEPTORS
4.1 Introduction
From experiments with nanoprobe 2 (see Chapter 3 for full details), it became
clear that our electrophile was not attaching to the surface of the receptor, even though
imaging studies suggested that we were targeting that same receptors as nanoprobe 1.
We had assumed the acrylamide moiety on nanoprobe 2 would conjugate to the receptor
of interest through proximity accelerated reactivity. In the absence of a suitable
nucleophile for bioconjugation, the nanoprobe 2 will simply be removed during the
multiple wash steps that occur during each activity based protein profiling experiment
that was performed to determine the receptor subtype we were targeting. Philanthotoxin,
and other polyamine toxins, are use-dependent meaning that only the open channels are
blocked. Use-dependency in polyamines has been well characterized 1 and there is a
voltage dependency which is also associated with them. Typically, intracellular
polyamines block AMPARs internally and result in an inward rectification of the evoked
current. Our polyamines are applied externally and prevent current influx. To remove
our polyamines, we must depolarize the membrane, which releases the block.1 Since our
acrylamide electrophile was not tagging, we can hypothesize that either it was being
excised from the channel before the Michael addition could occur, or there was not a
competent nucleophilic partner for crosslinking.
Keeping the current probe design in mind, we decided that we needed to change
our electrophile to one that would be less discriminating for covalent attachment to our
protein of interest. We decided to use an aryl azide, which adds to a protein of interest
via UV-induced photolysis, thus making nanoprobe 3 a photoaffinity probe. Once
photolysed, the probe has a highly reactive intermediate which can react with the closest
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neighboring partner, thus labeling the protein with the probe.2 A good photoaffinity probe
must be inert when added, only reacting when photolysed with UV-light; thus UVactivation of the photophore must not destroy the biomolecule of interest, and lifetime of
the activated photophore must be short, shorter than that of the ligand receptor
interaction.3 Once the activated photophore binds, the binding is covalent, and in an ideal
probe should not disrupt the natural dynamics of the receptors that it labels. The use of
photoaffinity labels also allows for identification of the amino acids that are involved in
binding to the probe, thus making an affinity label a good system for the detection of
calcium permeable AMPARs.
Previous photolabile philanthotoxin based probes have been synthesized. 4
Nakanishi and co-workers developed a photolabile probe targeted towards nicotinic
acetylcholine receptors (nAChRs), which are also targets of polyamine toxins. Much like
AMPARs, nAChRs are also ligand-gated, ion channels, but are sensitive to acetylcholine
and nicotine. They are comprised of five transmembrane subunits and are located in the
synaptic cleft. In their probe, the scaffold was based off of philanthotoxin 434 rather than
the philanthotoxin 433 that nanoprobe 2 and 3 are based on. The numbering system that
is used for these polyamines is to count the methylene units contained in the polyamine
tail.1a, 4bThis, and the addition of 125I, makes their photolabile probe have higher affinity
for nAChRs over AMPARs. Also, the 125I addition allowed for radiolabeling
experiments to study labeled receptors. 4b Our probe lacks the radiolabel, but has an
orthogonal handle which allows for affinity purification of the labeled lysate.
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4.2 Results
4.2.1 Nanoprobe 3 Design
We kept the major features of nanoprobe 2 in mind when designing nanoprobe 3.
Much like before, we designed nanoprobe 3 from a philanthotoxin scaffold. This was
done to create a probe that kept the features of philanthotoxin, yet could provide
information about the receptors we are targeting. For nanoprobe 3, we changed the
phenolic hydroxide to an azide for photoreactivity and bioconjugation to the surface of
the receptor. We then changed the butyl chain so it contains a Poc group for attachment
of an azide functionalized reporter tag. (Scheme 4.1)
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Scheme 4.1: Synthesis of nanoprobe 3

4.2.2 Initial Photolysis Testing With Nanoprobe 3
To confirm that nanoprobe 3 would undergo photolysis in times that would be
biologically relevant the molecule was irradiated under UV light (365 nm) for 1-10
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minutes to determine the minimum amount of time it takes for generation of the UV
byproduct. Formation of the nitrene product was monitored via LCMS analysis. We
determined that four minutes of irradiation by UV light is sufficient for biological studies.
(Figure 4.1) This is important because we did not want our protein to be degraded due to
the UV-light.
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Figure 4.1: Mass spectrum of nanoprobe 3 precursor after 4 minute UV
irradiation. Compound 17 (mw=276) was irradiated for 4 minutes with
365 nm light. Formation of the nitrene (mw=235) was observed.
Next, we wanted to confirm that nanoprobe 3 could label proteins. We
performed in vitro studies using nanoprobe 3 to test the photolysis reaction using bovine
serum albumin (BSA) and lysozyme. BSA and lysozyme were irradiated for 4 minutes
using UV light with nanoprobe 3 and then the proteins were subjected to chem ABPP as
described in Section 3.2.3 with rhodamine azide. Proteins were then separated on a 10%
SDS-PAGE gel and fluorescence was visualized using a Typhoon 9210 gel scanner.
(Figure 4.2) The results demonstrated that nanoprobe 3 is able to covalently label proteins
in vitro.
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BSA

Lysozyme

Figure 4.2: In-gel fluorescence of BSA and lysozyme labeled with nanoprobe 3.
BSA (70 kDa) and lysozyme (20 kDa) were labeled and irradiated with
nanoprobe 3 and separated using 10% SDS-PAGE gels. Labeling with
nanoprobe 3 was seen in when both light and copper were present.
4.2.3 Chemical Activity Based Protein Profiling of Cortex, Midbrain, and Cerebellum
Neurons with Nanoprobe 3
With the information that nanoprobe 3 was able to label proteins using in vitro
conditions, we next moved into labeling neurons to determine which receptors we were
targeting. Nanoprobe 3 is designed to targets calcium permeable AMPA receptors much
like nanoprobe 1 and 2, so by performing chem ABPP we should be able to determine
which receptor subtypes we are targeting. To 25 cm2 T-Flasks, 10 µM of nanoprobe 3
was applied for 5 minutes at room temperature and then the flasks were irradiated for 4
minutes with UV-light. Equimolar NAS to nanoprobe 3 controls were also done at the
same time. Cells were lysed using a probe sonicator, and the membranes were pelleted.
The membrane pellet was then lysed and the lysate underwent chem ABPP with either
azido rhodamine or azido biotin. Labeled lysates were separated on a 10% SDS-PAGE
gel. For rhodamine labeled protein gels, fluorescence was measured using a Typhoon
9210 scanner. For biotin labeled protein, 10 % SDS-PAGE gels were used to separate
protein, transferred to a nitrocellulose membrane, biotin was probed for using
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streptavidin-HRP, and imaged on a BioRad Protein Box. (Figure 4.3) Gels did not show
any labeled fluorescent bands. This may be due to the electrophile not being able to bind
to our protein of interest.

Figure 4.3: Cerebellum samples probed with nanoprobe 3. (Left)
Cerebellum samples run on a Western blot, probed with StrepHRP (1:10000) (Right) In-gel fluorescence of cerebellum
samples with rhodamine azide. No signal was seen in probe
labeled neuronal protein lanes.

4.2.4 Fixed Cell Imaging of Hippocampal and Cerebellar Neurons with Nanoprobe 3
Since the gel experiments appeared to lack any covalent labeling of the natively
expressed AMPARs, we took a step back and went back to imaging experiments with
neurons. Nanoprobe 3 contains an alkyne group for conjugation to the reporter tag, so it
is necessary to fix the neurons before the copper catalyzed click reaction of the reporter
tag. This is due to the toxic effects of copper on proteins. Neurons were labeled with
nanoprobe 3 for 5 minutes at room temperature and then irradiated with UV-light for 4
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minutes. Equimolar NAS to nanoprobe 3 controls were also prepared. Neurons were then
fixed in 4% paraformaldehyde for 10 minutes. They immediately underwent chem ABPP
with rhodamine azide and were washed ten times with 1x PBS. Coverslips containing
cells were then mounted on a glass slide with ProLong Gold Antifade. Coverslips were
imaged using epifluorescence microscopy; however fluorescent images were taken of all
samples. (Figure 4.4) Fluorescence accumulation was seen in samples targeted by
nanoprobe 3 and that had also been irradiated with UV-light. However, fluorescence
accumulation was also seen in the dark samples, and the equimolar NAS and nanoprobe 3
samples. We also saw fluorescence accumulation in samples which contained only
rhodamine azide. This suggests that the fixation process may have permeabilized the
membrane allowing for rhodamine azide to cross.
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Figure 4.4: Fixed neuronal imaging with nanoprobe 3. DIV 18hippocampal neurons
were labeled with nanoprobe 3, irradiated, and fixed in 4% paraformaldehyde.
They were then labeled with rhodamine azide with and without copper for click
chemistry. Controls were done in the presence of NAS, with just rhodamine,
and with nothing at all. Fluorescence signal was averaged over the positive
controls (n=8) and was set for all of the images. Fluorescence accumulation is
seen in all cases where rhodamine azide is present.

4.2.5 Fixed Cell Imaging of CHO Cells with Nanoprobe 3
Since we received confusing results from our imaging experiments with
nanoprobe 3, we decided to move into a simpler heterologous system of CHO cells
transfected with GluA1 (L497Y)-pIRES2-eGFP. Nanoprobe 3 was applied to the cells for
5 minutes and then irradiated for 4 minutes with UV light. Equimolar NAS to nanoprobe
3 controls were also prepared. Cells were then fixed using 4% paraformaldehyde and then
conjugated with rhodamine azide. Coverslips containing cells were then mounted onto
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coverglass with ProLong Gold Antifade. Coverslips were imaged using epifluorescence
microscopy. Again, fluorescence was seen in all cases, both probed containing samples
and the controls. (Figure 4.5)

Figure 4.5: GluA1 CHO cells labeled with nanoprobe 3. GluA1 CHO cells were
labeled with nanoprobe 3, irradiated, and fixed with 4% paraformaldehyde.
Fluorescence accumulation was averaged for with and without copper. The
samples containing no copper had a higher fluorescence accumulation.

We thought that the increase in fluorescence in all samples may be due to the
probe not being fully washed away. Multiple washes were performed ranging from 3-24
washes with 1x ECS prior to being fixed with 4% paraformaldehyde. Cells were then
orthogonally targeted with rhodamine azide and imaged via epifluorescence microscopy.
Again, fluorescence was seen in all cases. (Figure 4.6)
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Figure 4.6: Nanoprobe 3 labeled GluA1 CHO cells after multiple ECS washes. GluA1
CHO cells were labeled with nanoprobe 3, irradiated, washed 24 x 1mL with 1x
ECS, and then fixed with 4% paraformaldehyde. Fluorescence was set for the
with UV light samples. Fluorescence accumulation is similar in both cases.
We then hypothesized that the polyamine portion of nanoprobe 3 might not able
to leave the ion channel. To facilitate this, we depolarized the membrane using a high
KCl solution (1M). We placed this solution on the cells 1-4 times, washing three times in
between with 1x ECS. Cells were then fixed with 4% paraformaldehyde and labeled with
rhodamine azide. Cells were then imaged using epifluorescence microscopy. Again,
there were large amounts of fluorescence in all cases. (Figure 4.7)

Figure 4.7: Nanoprobe 3 labeled GluA1 CHO cells after KCl washes. GluA1 CHO
cells were labeled with nanoprobe 3, irradiated, washed 4 x 1mL with 1M
KCl, and then fixed with 4% paraformaldehyde. Fluorescence was set for the
with UV light samples. Fluorescence accumulation is similar in both cases.
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4.2.6 Chemical Activity Based Protein Profiling with GluA1 CHO Cells
To confirm that it is just the polyamine that is binding into the channel and that
our aryl azide electrophile is not tagging, chem ABPP was run on GluA1 CHO cells. To
60 mm2 petri dishes, solutions containing 10 µM nanoprobe 3 were placed on for 5
minutes at room temperature. Dishes were then irradiated for 10 minutes under UV-light
(no irradiation was used as a control) and cells were lysed using a probe sonicator. The
membranes were then pelleted and the membrane pellet was then lysed. The lysate was
then conjugated with biotin azide and separated on 10% SDS-PAGE gels. Biotin was
probed for by streptavidin-HRP and imaged using a BioRad imaging system. (Figure
4.8)

Figure 4.8: Western blot of GluA1 CHO cells labeled with nanoprobe 3. GluA1 CHO
cells were labeled with nanoprobe 3 and irradiated. Controls were performed
with CHO cells labeled with malemide alkyne and BSA. All samples were
lysed, separated on 10% SDS-PAGE gels, transferred to a nitrocellulose
membrane, and probed using streptavidin-HRP. Signal was only seen in the
positive controls, not in samples labeled with nanoprobe 3.
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4.3 Discussion
Nanoprobe 3 was designed from a scaffold of philanthotoxin-433. Much like
nanoprobe 2, the rationale for designing this probe was to allow us to determine which
subunits comprise calcium permeable AMPARs. To do so, we designed the probe so that
it contained an aryl azide for photocrosslinking bioconjugation to the surface of the
receptor. Mass spec experiments were conducted to determine the minimum amount of
time that is need to fully photolyse the probe, which was determined to be four minutes.
Initial testing of the probe was conducted in vitro using BSA and lysozyme and
demonstrated that we were able to label both proteins.
We then began testing nanoprobe 3 in neurons. Initial testing took place in
dissociated cultures of rat cortex, midbrain, and cerebellar neurons. We probed using
azido labeled rhodamine, fluorescein, and biotin for the detection of labeled subunits. The
in-gel fluorescence and Western blot data showed that nanoprobe 3 is not covalently
binding to the receptors of interest, or for that matter, any receptors in the neuronal
samples. However, coomassie staining showed that there was indeed protein present on
the gels and our control samples of BSA that were irradiated with the same probe work.
A subsequent silver stain was done on other gels to again show the presence of protein,
and to determine if there is any difference in labeling. (Figure 4.9) We were not able to
visualize any fluorescent bands using either the fluorophore azide or the biotin azide,
suggesting that the probe was not covalently attaching to the surface of the protein.
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Figure 4.9: Silver stain of SDS-PAGE gel of nanoprobe 3 labeled cerebellum
samples. Protein is present when the gel is silver stained, however, we
do not see any protein bands in the fluorescence gels or the Western
Blots.
We then wanted to see if we are targeting the same receptor sites that nanoprobe
1 and nanoprobe 2 targeted. In this case, we were not able to do live cell imaging as we
did before, as we need to use copper to attach our reporter tag to the probe. Copper can be
very toxic when introduced to biological systems at the amounts needed to catalyze click
reactions. Unlike nanoprobe 2, the addition of the reporter prior to cell imaging would be
difficult as nanoprobe 3 contains both an azide, albeit an arylazide, and alkyne on the
same molecule. We wanted to limit these toxic effects, so we fixed the neurons prior to
applying azido-rhodamine for visualization. Here, we received very confusing results as
some coverslips behaved as we expected and others did not. Our control coverslips, those
that were non-irradiated and/or contained NAS, had fluorescence accumulation equal to
or higher than that of the fully irradiated probe samples. This could be due to nanoprobe
3 being internalized in vesicles prior to fixation with 4% paraformaldehyde. 5 Here, we
could not be able to tell if nanoprobe 3 was attached to the surface of the receptor, on that
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it was present when the cells were fixed. Also, the rhodamine dye might be an issue as
well. (Figure 4.4) In control samples in which only rhodamine azide was present, there
was a large amount of somal staining, as well as dendritic staining. This suggests that the
rhodamine azide is non-specifically targeting the membranes even after fifteen wash
steps with 1x PBS. We cannot use a green fluorophore, as neurons autofluorescence at
the 488 nm excitation for FITC and, as a result, use of another red fluorophore would
give us better information.
We then moved into a heterologous system of CHO cells stably transfected with
GluA1. This represents a model calcium permeable AMPA receptor. GluA1 CHO cells
were subjected to the same treatment as the neurons and probed using azido rhodamine.
As with the neurons, we observed prodigious staining of the cell body which appeared to
be non-specific. We wanted to then test if we could possibly remove nanoprobe 3 from
the ion channel through either multiple wash steps or through depolarization of the
membrane. Polyamine toxins block the ion current that goes through glutamatergic
receptors and in neurons would be removed when the electrochemical gradient in the
membrane shifts and depolarizes the membrane.6 This can also be done through chemical
methods by using a high KCl solution. GluA1 CHO cells were washed up to 24 times
with 1x PBS to try to remove the probe from the ion channel. GluA1 CHO cells were also
washed with 1M KCl up to four times to depolarize the membrane, again to try to remove
nanoprobe 3 from the ion channel before fixation. Again, there was no significant
difference in cells that were either washed or depolarized compared to the control.
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Figure 4.10: CHO cells labeled with malemide alkyne with and without
copper

We then tried chem ABPP on GluA1 CHO cells this time affixing biotin azide to
the probe. Controls were done using non-transfected cells labeled with malemide alkyne
(Figure 4.10). Cells were irradiated for 10 minutes in this case to ensure that nanoprobe 3
was labeling. Probing with streptavidin-HRP showed that nothing was labeled in the
probe lanes, but the control lanes were labeled. This means that our click conditions are
working just fine, but nanoprobe 3 is not. One potential reason is that the nitrene that is
formed is reacting with water in the binding pocket.7 When the activate photophore is
formed, it is indiscriminate in its binding partner and will react with to the closest
neighboring molecule. In this case, it could be the OH of water and not the CH of the
nearest amino acid in the binding pocket. All of these results, taken together, suggest that
nanoprobe 3 does not function as a suitable probe for the detection of calcium permeable
AMPARs.
A better probe should take into account some of the design details that were
incorporated into nanoprobe 1. The main difference between nanoprobe 1 and
nanoprobes 2 and 3 is the placement of the electrophile to the targeting polyamine. It
might be fruitful to move the position of the electrophile so that it can explore the same
target space as nanoprobe 1. A better design for these nanoprobes will be described in
chapter 6.

98

4.4 Methods
4.4.1 General Methods
All reagents were purchased through Fisher Scientific (Fair Lawn, NJ, USA)
unless otherwise noted. FAM-5 azide was purchased from Lumiprobe (Hallendale Beach,
FL, USA). All moisture sensitive reactions were done under an argon atmosphere using
a syringe-septum cap technique. Dry dimethylformamide (DMF) and acetonitrile
(MeCN) were purchased from Sigma Aldrich (St. Louis, MO, USA). Analytical thin
layer chromatography (TLC) was carried out on Merck Silica gel 60 F254 glass plates
and visualized using UV light (254 nm), ninhydrin or bromocrestol green stain. Sorbent
Technologies (Atlanta, GA, USA) silica gel (230-450 mesh) was used for flash
chromatography. 1H NMR and 13C NMR spectra were collected on a 400 MHz Bruker
NMR spectrometer using the residual proton or carbon resonance of the solvent as the
standard. Chemical shifts are reported in parts per million (ppm). The following
abbreviations are used for peak multiplicities: s, singlet; d, doublet; dd, doublet of
doublets; t, triplet; m, multiplet. Mass spectra were measured using either a Waters ZQ
for LCMS, or at the UMass Mass Spec facility for HRMS, UMass Amherst.
4.4.2 Synthesis of nanoprobe 3
O
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13

(S)-2-amino-3-(4-nitrophenyl)propanoic acid(13)
L-phenylalanine (15.0 g, 90.8 mmol) was dissolved in H2SO4 (45 mL) and a
mixture of HNO3 (4.50 mL, 108.9 mmol) in H2SO4 was added dropwise at 0°C. The
solution was warmed to room temperature and stirred for 4 hours and then poured onto
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ice (50 g) and neutralized with solid NaOH until pH equaled 7 using pH paper. A solid
white precipitate was filtered, dried, and was used without further purification as it was
spectroscopically identical to literature (10.41 g, 55 % yield).8
O

O
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O2N
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NH2
13

O2N

NH2

14

(S)-Ethyl 2-amino-3-(4-nitrophenyl)propanoate (14)
To a stirred suspension of compound 13 (5.0 g, 23 mmol) in ethanol (40 mL),
SOCl2 (2.07 mL, 28.5 mmol) was added dropwise and the reaction was heated to reflux
overnight. The solvent was removed in vacuo and the product was purified via column
chromatography using 10:1 CH2Cl2:CH3OH as the mobile phase. A solid white
precipitate was filtered, dried, and was used without further purification as it was
spectroscopically identical to literature (2.97 g, 53% yield) 9
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(S)-Ethyl 2-amino-3-(4-nitrophenyl)propanoate(15)
Compound 14 (2.95 g, 338.8 mmol) was dissolved in ethanol (50 mL) and was
treated with Sn (II)Cl2 (5.92 g, 26.3 mmol) at reflux for 18 h. The solution was then
cooled to room temperature, poured on ice (50 g), and made basic (pH equaled to 9)
using sat. NaHCO3. The solution was then filtered through Celite and washed with
CH2Cl2. It was then extracted with brine, dried over MgSO4 (anhyd.), and the solvent
was removed in vacuo. The product was recovered as a white solid. (2.97 g, 53% yield)
1H

NMR (400 MHz, CDCl3) d ppm 6.98 (d, J=8.34 Hz, 2 H) 6.63 (d, J=8.34 Hz, 2 H)

4.17 (q,J=7.16 Hz, 11 H) 3.65 (dd, J=7.45, 5.43 Hz, 5 H) 2.98 (dd, J=13.64, 5.31 Hz, 6
H) 2.77 (dd, J=13.77, 7.71 Hz, 7 H) 1.26 (t, J=7.20 Hz, 17 H).
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(S)-Ethyl 2-amino-3-(4-azidophenyl)propanoate (16)
Compound 15 (1.40 g, 4.5 mmol) was dissolved in aqueous 2 N HCl and cooled
to 0°C. To that, NaNO2 (319 mg, 4.6 mmol) dissolved in water (3.6 mL) was slowly
added. The reaction was stirred for 15 minutes and NaN3 (301 mg, 4.6 mmol) dissolved in
water (7.2 mL) was added dropwise. The reaction mixture was then warmed to room
temperature and then stirred for an additional 30 minutes. The reaction mixture was then
poured into deionized water (50 mL) and made basic with saturated NaHCO3. The
solution was extracted into ethyl acetate (3 x 20 mL), dried over anhydrous sodium
sulfate, and filtered. The solvent was removed in vacuo. The product was recovered as a
white solid. (1.40g, 89% yield) 1H NMR (400 MHz, CDCl3) ppm 7.18 (d, J=8.34 Hz, 2
H) 6.91 - 6.97 (m, 2 H) 4.15 (q, J=7.07 Hz, 13 H) 3.03 (dd, J=13.64, 5.31 Hz, 6 H) 2.84
(dd, J=13.64, 7.58 Hz, 6 H) 1.20 - 1.27 (m, 21 H).
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(S)-Ethyl 3-(4-azidophenyl)-2-(((prop-2-yn-1-yloxy) carbonyl) amino)propanoate
(17)
Compound 16 (1.32 g, 5.63 mmol) and triethylamine (942 µL, 6.76 mmol) were
dissolved in CH2Cl2 (5 mL) and cooled to 0°C. Propargyl chloroformate (550 µL, 5.63
mmol) was dissolved in CH2Cl2 (30 mL) and was added slowly to the reaction mixture.
The reaction was warmed to room temperature and stirred overnight. The reaction
mixture was diluted with CH2Cl2 and underwent a water work-up (3 x 20 mL). The
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extract was dried over anhydrous sodium sulfate, filtered, and then evaporated in vacuo.
The residue was purified using column chromatography using 10:1 CH2Cl2:CH3OH as
the mobile phase. The product was recovered as an yellow oil. ( 0.759 g, 44.8% yield) 1H
NMR (400 MHz, CDCl3) ppm 7.13 (d, J=8.34 Hz, 2 H) 6.94 - 6.99 (m, 2 H) 5.32 (s, 3
H) 4.63 - 4.71 (m, 2 H) 4.19 (dd, J=7.07, 1.77 Hz, 2 H) 3.11 (dd, J=15.66, 5.81 Hz, 2 H)
2.50 (t, J=2.53 Hz, 1 H) 1.27 (t, J=7.20 Hz, 3 H).
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(S)-3-(4-azidophenyl)-2-(((prop-2-yn-1-yloxy)carbonyl)amino)propanoic acid (18)
Compound 17 (730 mg, 2.31 mmol) was dissolved in methanol (15 mL) and
treated with aqueous 1M KOH (3.46 mL, 3.46 mmol) overnight. The solution was
neutralized with 1M citric acid (5 mL) and concentrated. The residue was diluted with
water (10 mL) and acidified to pH equal to 2 with 1M citric acid monitored using pH
paper. The resulting mixture was extracted into CH2Cl2 and the solvent was removed in
vacuo. The product was recovered as an yellow oil. (0.3985 g, 49 % yield) 1H NMR (400
MHz, CDCl3) ppm 7.14 - 7.21 (m, 2 H) 6.99 (d, J=8.34 Hz, 2 H) 5.27 - 5.34 (m, 8 H)
4.65 - 4.71 (m, 2 H) 3.22 (dd, J=14.02, 5.43 Hz, 8 H) 3.05 - 3.15 (m, 6 H) 2.51 (t, J=2.40
Hz, 6 H) 1.41 - 1.50 (m, 14 H).
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(S)-Tert-butyl (3-(3-(4-azidophenyl)-2-(((prop-2-yn-1yloxy)carbonyl)amino)propanamido)propyl)(4-((tert-butoxycarbonyl)(3((tert-butoxycarbonyl)amino)propyl)amino)butyl)carbamate (19)
Compound 18 (31 mg, 0.108 mmol) was dissolved in CH2Cl2 (5 mL) along with
EDC (27 mg, 0.140 mmol) and HOBt (21 g, 0.140 mmol) for 15 minutes, then triBoc
spermine (54 mg, 0.108 mmol) was added. The reaction mixture was placed under argon
and stirred overnight at room temperature. The solvent was evaporated and the crude
mixture was taken up in ethyl acetate (10 mL) and underwent an acid/base extraction
with 1 N HCl (2x 10 mL) and 1 N NaOH (2x10 mL). The organic fraction was dried over
anhydrous sodium sulfate, filtered, and the solvent was removed in vacuo. The product
was recovered as a white solid. (43 mg, 51.7% yield) LCMS=772.9
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(S)-(3-(3-(4-azidophenyl)-2-(((prop-2-yn-1-yloxy) carbonyl)
amino)propanamido)propyl) (4-(carboxy(3-(carboxyamino)
propyl)amino)butyl) carbamic acid (20)
Compound 19 (43 mg, 0.0557 mmol) was taken up in 200 proof ethanol (3 mL)
and acetyl chloride (0.75 mL) was added in dropwise to produce a 1M anhydrous HCl
solution. The reaction was stirred overnight, hexanes (1 mL) was added to precipitate the
product, and solvent was removed in vacuo. The product was recovered as an yellow oil.
(36.7 mg, 90 % yield) LCMS= 472.8
4.4.3 Chemical Activity Based Protein Profiling on Bovine Serum Albumin and Lysozyme
5 µL of 2.0 mg/mL BSA or lysozyme was placed in 50 µL of 1x PBS and 1 mM
of nanoprobe 3. Samples were irradiated for 4 minutes with 365 nm light. Control nonirradiated samples were also prepared. Samples were then subjected to chemical ABPP.
Master mixes for click solutions were set up with 1 mM CuSO4*5H2O (50 mM stock),
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100 µM THPTA (1.7 mM stock), and freshly prepared 1 mM TCEP (50 mM stock).
These incubated for 10 minutes and 10 µM of rhodamine azide. A separate control master
mix was prepared by substituting deionized water in for the CuSO4*5H2O.. Samples were
then separated on a 10% SDS-PAGE gel and fluorescence was measured using a
Typhoon 9210 imager.
4.4.4 Dissociated Culture of Rat Cortex, Midbrain, and Cerebellar Neurons
Primary dissociated cortex, midbrain, and cerebellar cell cultures were prepared
from embryonic day E18-20 Sprague-Dawley rat embryos and were cultured on 25 cm2
T-Flasks or 60 mm2 petri dishes coated in poly-lysine in serum containing media
identical to previous reports.10 Cerebellar culture media was supplemented with 1M
potassium chloride (1 mL in 50 mL).11 Cells were grown in 5% CO2 at 37°C. All animal
care and experimental protocols were approved by the Animal Care and Use Committee
at University of Massachusetts, Amherst, Amherst, MA, USA.
4.4.5 Chemical Activity Based Protein Profiling on Rat Cortex, Midbrain, and Cerebellar
Neurons
Cultures of neurons from of cortex, mid-brain, and cerebellum were grown on 25
cm2 T-flasks (or 60 mm2 petri dishes) were grown to a point where they were synaptically
active (DIV 14-18). Flasks were washed three times with extracellular recording buffer.
5 mL of 10 µM of nanoprobe 3 in extracellular solution with 20 µM glutamate was
applied for 5 minutes at room temperature. Cells were then irradiated with 365 nm light
for 4 minutes. Control samples were prepared either by non-irradiation with UV light or
as equimolar mixtures of NAS and nanoprobe 3 with and without UV light. Flasks were
then washed three more times with extracellular solution. To this, 1 mL of lysis solution
(1x PIC, 1x PBS) was added to each flask and cells were scrapped to remove from sides
of the T-flask. Cells were lysed with a probe sonicator 30% power for 1 minute, and the
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membrane portions were pelleted. The membrane pellet was lysed again using the same
conditions and a BCA assay was run to quantitate protein concentrations. Master mixes
for click solutions were prepared with 1 mM CuSO4*5H2O (50 mM stock), 100 µM
THPTA (1.7 mM stock), and freshly prepared 1 mM TCEP (50 mM stock). These
lysates were incubated for 10 minutes and 10 µM of either rhodamine azide or biotin
azide were then added. A separate control master mix was prepared by substituting
deionized water in for the CuSO4*5H2O. To an Eppendorf tube, 50 µL of cell lysate and
the appropriate master mix were added to the tube with the reaction going for one hour.
Samples were then separated on a 10% SDS-PAGE gel. For in-gel fluorescence
experiments, gels were placed into 10% acetic acid and imaged using a Typhoon 9210
imager. For Western blot experiments, proteins were transferred to a nitrocellulose
membrane and probed against streptavidin HRP. HRP was activated using SuperSignal
West Pico Chemiluminescence Substrate. Chemiluminescence was measured using a
BioRad imaging system.
4.4.6 Dissociated Culture of Rat Hippocampal and Cerebellar Neurons
Primary dissociated cerebellar cell cultures were prepared from embryonic day
E18-19 Sprague-Dawley rat embryos and were cultured on polylysine-coated coverglass
(12mm, 1.0 size) in serum-containing media identical to previous reports. 11 Cells were
grown in 5% CO2 at 37°C. All animal care and experimental protocols were approved by
the Animal Care and Use Committee at the University of Massachusetts Amherst,
Amherst, MA, USA.
4.4.7 Fixed Cell Imaging of Rat Hippocampal and Cerebellar Neurons
Coverslips containing neurons were grown until they were synaptically active
(DIV 14-18). Three imaging solutions were prepared: a sham solution containing 4 mL
of 1x ECS and 20µM l-glutamate, 8 mL of 10 µM of nanoprobe 3 in 1x ECS with 20 µM
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l-glutamate, and 8 mL of equimolar 10 µM nanoprobe 3 and NAS in 1x ECS with 20
µM l-glutamate. Coverslips were washed three times with 1x ECS and probe solutions
were applied for 5 minutes at room temperature. Appropriate coverslips were irradiated
with UV (365nm) light for 4 minutes, and dark controls were left in the dark for the same
amount of time. Coverslips were then washed three times with 1x ECS. All coverslips
were fixed in 4% paraformaldehyde for 8 minutes and were then washed three times with
1x PBS. Click solutions (1 mM CuSO4*5H2O (50 mM stock), 100 µM THPTA (1.7 mM
stock), freshly prepared 1 mM TCEP (50 mM stock), and 10 µM rhodamine azide (10
mM stock)) were placed onto the coverslips. Control solutions were also prepared using
deionized water in place of CuSO4*5H2O. Coverslips were then washed six times with 1x
PBS and mounted onto coverglass using ProLong Gold Antifade. Coverslips cured
overnight and were sealed using clear nail polish.
Hippocampal and cerebellar neurons were imaged by excitation with a light from
a Sutter Lambda-LS illuminator (Sutter Instruments, Novato, CA,USA). A Nikon Eclipse
Ti series microscope (Nikon Corps, Tokyo, Japan) with a CFI Plan Apo VC 60X 1.4 NA
oil objective lens (Nikon) was employed for all imaging epifluorescence experiments.
The Cy-3 filter cue contained a 540/30 excitation filter, a 570 DRLP dichroic mirror, and
575 ALP emission filter (all from Omega Optical Corp., Brattleboro, VT, USA). Images
were acquired using a Hamamatsu ORCA ER camera (Hamamatsu, Hamamatsu City,
Japan) and NIS Elements BR 3.1 software (Nikon Corps, Melville, NY, USA).
Images were analyzed using ImageJ (U.S. National Institutes of Health,
Bethesda, MD, USA). The mean of the minimum and maximum overall fluorescence
values were set for all images collected from each of the 16 coverslips (32 in all). Images
were not further analyzed as analysis by eye could tell there were differences between the
nanoprobe 3 and control images.
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4.4.8 Cell Culture of GluA1 CHO Cells
A stable cell line was prepared by Nate Johnson in the lab. Cells were grown to
they were 70% confluent on cover glass (12mm, 1.0 size) in Hams-F12 media containing
10% FBS. Cells were grown at 5 % CO2 at 37°C.
4.4.9 Fixed Cell Imaging of GluA1 CHO Cells
Coverslips containing CHO cells were grown until they were 70-85% confluent.
Two imaging solutions were prepared: 8 mL of 10 µM of nanoprobe 3 in 1x ECS with 20
µM l-glutamate, and 8 mL of equimolar 10 µM nanoprobe 3 and NAS in 1x ECS with 20
µM l-glutamate. Coverslips were washed three times with 1x ECS and probe solutions
were applied for 5 minutes at room temperature. Appropriate coverslips were irradiated
with UV (365nm) light for 4 minutes, and dark controls were left in the dark for the same
amount of time. Coverslips were then washed three to twenty four times with 1x PBS for
washing experiments. For depolarization experiments, cells were washed one to four
times with 1M KCl, washing three times with 1x PBS in between each addition.
All coverslips were fixed in 4% paraformaldehyde for 10 minutes and were then
washed three times with 1x PBS. Click solutions (1 mM CuSO4*5H2O (50 mM stock),
100 µM THPTA (1.7 mM stock), freshly prepared 1 mM TCEP (50 mM stock), and 10
µM rhodamine azide (10 mM stock)) were placed onto the coverslips. Control solutions
were also prepared using deionized water in place of CuSO4*5H2O. Coverslips were then
washed six times with 1x PBS and mounted onto coverglass using ProLong Gold
Antifade. Coverslips cured overnight and were sealed using clear nail polish.
GluA1 CHO cells were imaged by excitation with a light from a Sutter LambdaLS illuminator (Sutter Instruments, Novato, CA,USA). A Nikon Eclipse Ti series
microscope (Nikon Corps, Tokyo, Japan) with a CFI Plan Apo VC 60X 1.4 NA oil
objective lens (Nikon) was employed for all imaging epifluorescence experiments. The
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Cy-3 filter cue contained a 540/30 excitation filter, a 570 DRLP dichroic mirror, and 575
ALP emission filter (all from Omega Optical Corp., Brattleboro, VT, USA). Images were
acquired using a Hamamatsu ORCA ER camera (Hamamatsu, Hamamatsu City, Japan)
and NIS Elements BR 3.1 software (Nikon Corps, Melville, NY, USA).
Images were analyzed using ImageJ (U.S. National Institutes of Health,
Bethesda, MD, USA). The mean of the minimum and maximum overall fluorescence
values were set for all images collected from each of the coverslips.
4.4.10 Chemical Activity Based Protein Profiling of GluA1 CHO Cells
60 mm2 petri dishes of GluA1 CHO cells and CHO cells were grown until they
were 90% confluent. Petri dishes were washed three times with extracellular recording
buffer. 5 mL of 10 µM of nanoprobe 3 in extracellular solution with 20 µM glutamate
was applied for 5 minutes at room temperature. Cells were then irradiated with 365 nm
light for 4 minutes. Control samples were prepared either by non-irradiation with UV
light. Control non-transfected samples were treated for 5 minutes with TCEP and
incubated with 10 µM malemide alkyne for 30 minutes at 37°C. Petri dishes were then
washed three more times with extracellular solution. 1 mL of lysis solution (1 x PIC, 1x
PBS) was added to each dish and cells were scrapped to remove cells from the bottom of
the dish. Cells were lysed with a probe sonicator 30% power for 1 minute, and the
membrane portions were spun down. The membrane pellet was lysed again using the
same conditions and a BCA assay was run to quantitate protein concentrations. Master
mixes for click solutions were set up with 1 mM CuSO4*5H2O (50 mM stock), 100 µM
THPTA (1.7 mM stock), and freshly prepared 1 mM TCEP (50 mM stock). These
incubated for 10 minutesutes and 10 µM of either rhodamine azide or biotin azide were
then added. A separate control master mix was prepared by substituting deionized water
in for the CuSO4*5H2O. 50 µL of cell lysate were removed and the appropriate master
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mix was added to the tube with the reaction going for one hour. Samples were then
separated on a 10% SDS-PAGE gel. For Western blot experiments, proteins were
transferred to a nitrocellulose membrane and probed against streptavidin HRP. HRP was
activated using SuperSignal West Pico Chemiluminescent Substrate. Chemiluminescence
was measured using a BioRad imaging system.
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CHAPTER 4
LABELING OF BIOLOGICAL SYSTEMS USING PHOTOGENERATED DIAZONIUMS
5.1 Introduction
Understanding and visualizing how proteins react in vivo has become a popular
topic in the past 15 years. Current methods for labeling biological systems involve either
modifying the protein of interest with a fluorescent reporter or by targeting the protein
using small-molecule probes which contain organic fluorophores. These organic
fluorophores can more easily be changed out for different imaging experiments when
compared to genetic manipulations. Further, one has the ability to modify biomolecules
such as glycans and lipids using bioorthoginal strategies. A typical chemical probe
contains a targeting ligand, a reactive partner for attachment, and a reporter tag for
visualization. These probes are designed in such a way that is orthogonal to the function
of the receptor, termed bioorthogonal chemistry. There are a number of reactions that fall
under the term bioorthogonal chemistry, including 1,3-dipolar cycloadditions (click
reactions), hydrazine/oxime formation from aldehydes and ketones, tetrazine ligation,
isocyanide based click reactions, and quadricyclane ligation.1 A full discussion of these
can be found in section 1.3. Use of bioorthogonal probes is a two-step process in which
the probe targets the protein of interest and then a reporter tag is added for visualization.
A well designed probe for bioorthogonal chemistry is one that will not interrupt
function of the biomolecule target, can withstand the environment of the cell, yet can still
react with its intended target, and the reaction does not produce a toxic byproduct.2 One
of the most common type of bioorthogonal reactions is the 1,3-dipolar cycloaddition.
Click reactions involve the reaction of an azide labeled moiety forming a triazole with an
alkyne labeled moiety. These reactions can be copper mediated or strain mediated.
Strain mediated cycloadditions have been used in a variety of bio-systems such as
proteins, live-cells, and living animals,3 and are preferable over copper mediated
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reactions as there is no introduction of toxic amounts of copper to promote triazole
formation. However, when using strain-mediated cylcoadditions the biosystem of
interest must be labeled with a bioorthogonal group, such as an azide. Most of the time,
this means an azido sugar is fed to the organism, or the protein is covalently labeled with
an azide. Also, the cylcooctyne containing reporter tag can undergo attack by thiols
contained on the biosystem of interest, thus leading to conjugation in areas not targeted
by the reporter.2
Another method of tagging a biosystem of interest is through the use of
photoaffinity labeling. This includes the use of benzophenones, aryl azides, and 3(trifluoromethyl)-3-phenyldiazirine.4 Photoreactive probes can provide spatial
information about how proteins interact with each other. This is due to the indiscriminate
nature of the activated photophore, as it will react with the nearest neighboring
molecule.4 The aspects of a good photoprobe were covered in Section 4.1, and share
overlap with the aspects of a good bioorthogonal probe listed above; chiefly, the probe
not interfering with the mechanism of action of the protein of interest. An ideal probe for
looking at protein interactions with high spatial-temporal resolution should then
incorporate aspects from both photoaffinity labeling and bioorthoginal reactivity.
Aryl diazonium salts have been used to photolabel a number species due to their
ability to undergo nucleophilic aromatic substitutions.4-5 Upon photolysis, the aryl
diazonium generates a highly reactive aryl cation, which is super-reactive and will not
rearrange in the excited state. They also bind to the closest nucleophilic partner, including
C-H bonds, quickly, so that there is little time for them to exit from the active site of the
receptor of interest. 6
A few attempts at this exact design have been produced and have been termed
“photoclick” probes. Lin in 2008 7 used terminal alkenes to induce photoactivated, nitrile
imine mediated 1,3-dipolar cycloadditions in E. coli. Their method involved
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incorporating O-allyl-tyrosine into E.coli Z-domain and applying probe molecules
containing diaryl tetrazoles. After a 10 min irradiation with UV-light and SDS-PAGE
analysis, they were able to tag their modified E. coli proteins. 7 In 2009, Poptik designed
a photo-caged cyclooctyne by masking the alkyne as a photo-reactive cyclopropenone.
Upon irradiation, the cyclopropenone transforms to the cyclooctyne which is ready for
conjugation with an azide. In their cell experiments, CHO cells were grown with nazidoacetylmannosamine to produce the metabolite n-azido-diacetyl-sialic acid. Their
protected biotinylated probes were incubated with cells for an hour, irradiated with UV
light for 1 minute, and then incubated for an additional hour to facilitate the cycloaddition
reaction. CHO cells were then fixed and stained with avidin-FITC for detection.8 This
cyclopropenone protected cyclooctyne method was then further adapted for use with
enzyme mediated azide ligation.9
These methods extend the idea of “photoclick” reaction, but still rely on the
biosystem of interest being tagged in some fashion with the bioorthogonal group days
beforehand. This is done by manipulation of the system with either a point mutation or
by having the cell produce an azido metabolite. A probe which quickly targets a
biomolecule of interest produces an active, targetable species upon irradiation, and
specifically couples with an appropriate reporter is still desired.
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5.2 Results
5.2.1 Live Cell Imaging of CHO Cells Using Oleic TBA and Cy-3 DHPP

Figure 5.1: Structure of Oleic TBA and Cy-3 DHPP

Our new probe is based upon an oleic acid scaffold as it will partition into the
cell membrane. (Figure 5.1) Other directly fluorescent probes have been made from this
scaffold. 10 Our probe incorporates oleic acid so it contains an ortho-triazine benzonic
acid head group which is able to undergo photochemistry yielding a diazonium
carboxylate. Our targeting molecule is Cy-3 DHPP, (Cy-3 dihydroxyphenyl piperazine,
Figure 5.1) which contains an electron rich aromatic ring for attachment to the
photogenerated diazonium species. CHO cells were incubated with 10 µM oleic TBA for
15 minutes at 37°C in their home media. They were then washed via perfusion and
photolysed. 1 µM Cy-3 DHPP was added for 15 seconds and cells were washed for 2
minutes before fluorescence images were captured. Controls were performed using
DMSO as a sham treatment. We saw very little difference in the treated versus sham
treated cells. (Figure 5.2)
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Figure 5.2: CHO cells labeled with oleic TBA and Cy-3 DHPP. CHO cells
were incubated 10 µM oleic TBA for 15 min at 37°C and 1 µM Cy-3
DHPP for 15 seconds. Controls were done with DMSO. There was
not a significant increase in fluorescence over the controls.

5.2.2 Live Cell Imaging of CHO Cells Using Oleic TBA and Cy-3 DMAPP
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Figure 5.3: Structure of Cy-3 DMAPP

It was clear to us that the DHPP scaffold was far too reactive, so we decided to
move to one that might be less so. Our new reporter tag was now Cy-3 DMAPP
(dimethylaminophenyl piperazine, Figure 5.3) As before, CHO cells were incubated in
their home media for 15 minutes with 1 µM oleic TBA, washed via perfusion, and
photolysed for 15 seconds. Cy-3 DMAPP was applied for 15 seconds, and cells were
115

washed for 2 minutes. Fluorescence images were then collected. Sham DMSO treatments
were also conducted as controls. Again, we only saw slight differences in the probed
cells versus those that had the sham treatment. (Figure 5.4)

Figure 5.4: Live CHO cell imaging with Cy-3 DMAPP. CHO cells were
incubated 1 µM oleic TBA for 15 min at 37°C and 1 µM Cy-3
DMAPP for 15 seconds. Controls were done with DMSO. There
was not a significant increase in fluorescence over the controls.

5.2.3 Live Cell Imaging of CHO Cells Using Oleic TBA and Biotin-DMAPP
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Figure 5.5: Structure of biotin-DMAPP
We were not sure if it was our Cy-3 fluorophore itself that was crossing the
membrane or otherwise being endocytosed by cells, so we decided to switch reporter
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tags. Our new probe contained the same electron-rich targeting core (DMAPP), but now
had biotin installed for detection. (Figure 5.5) This allowed us to use an avidin-tagged
fluorophore for fluorescence reporting as excess avidin will be washed away by
perfusion. CHO cells were incubated with 1 µM oleic-TBA for 15 minutes in their home
media and washed via perfusion. Cells were then irradiated with UV light for 15 sec, and
incubated with probe for 15 sec. Cells were then washed for 2 minutes, incubated with
1:100 avidin-FITC 11 washed for another 2 minutes, and imaged fluorescently. Controls
this time were a DMSO sham and non-irradiated samples containing the probe.
Fluorescent accumulation was seen along the cell membrane in irradiated cells, but not in
the control samples. (Figure 5.6)

Figure 5.6: Live CHO cells imaged with oleic TBA and biotin-DMAPP. CHO cells were
incubated 1 µM oleic TBA for 15 min at 37°C ,1 µM biotin DMAPP for 15
seconds, and 1:100 FITC avidin for 2 min . Controls were done with DMSO and
non-irradiation of oleic-TBA. Cells treated with both UV-light and avidin-FITC
had an increase in fluorescence along membranes.
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5.3 Discussion
Spatially and temporally controlled labeling of proteins using bioorthogonal
methods is the future of where the field is heading in order to get real time information
about protein dynamics and how cells function. Currently, there are a few methods
available in order to be able to achieve this, but they suffer from the need of having an
orthogonal reporter tag installed either genetically or metabolically prior to photo
activation. Our approach is the first to develop a method that would allow for targeting a
protein of interest target, then to target a photoactivated species with a reporter probe. To
do so our targeting probe contained a triazine benzoic acid and our reporting probe
containing an electron rich aromatic ring which attaches itself to a diazonium resulting
from photolysis of the targeting probe.
The first version of the reporter probe contained a dihydroxyphenyl piperazine as
our electron rich aromatic ring, conjugated to Cy-3 for visualization. Application of the
probe targeted areas on the cell membrane, but sham controls with DMSO also
demonstrated fluorescence accumulation in the membrane as well. The same effect of
fluorescent accumulation in the sham samples was also seen when the electron rich
aromatic targeting group was changed to dimethylaminophenyl piperazine. DMSO has
been known to permeabilize membranes, 12 allowing for fluorophores to slowly leak in at
higher concentrations of DMSO. Molecular dynamic simulations of lipid membranes
with DMSO show that small pores can be formed in the dipalmitoyl-phosphatidylcholine
bilayer, which could be a way for small molecules to get through the lipid bilayer. 12c, 13 It
is also possible that the free fluorophore is diffusing across the cell membrane and
accumulating in the cytosol. 14
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We decided to change our reporter tag to biotin so that we can then tag with an
avidin labeled fluorophore. The avidin labeled fluorophore should not cross the cell
membrane, thus any fluorescence accumulation would be from avidin labeling biotin. We
see precisely this result in our biotin DMAPP probed cells. In control samples with
DMSO, there was no fluorescence uptake. More importantly, there was no fluorescence
accumulation when the oleic-TBA probe was not irradiated. This strongly suggests that
there is only binding of the reporting probe, when the targeting probe has been
photoactivated, indicating that our probe is capable of photoclick chemistry. This has
also been confirmed in SDS-PAGE gels on acyl carrier protein (data not shown).
Further probes would need to be ligand directed to confirm binding at specific sites,
rather than global membrane binding.
5.4 Methods
5.4.1 General Imaging Methods
CHO cells were imaged by excitation with a light from a Sutter Lambda-LS
illuminator (Sutter Instruments, Novato, CA,USA). A Nikon Eclipse Ti series microscope
(Nikon Corps, Tokyo, Japan) with a CFI Plan Apo VC 40X objective lens (Nikon) was
employed for all imaging epifluorescence experiments. The Cy-3 filter cube contained a
540/30 excitation filter, a 570 DRLP dichroic mirror, and 575 ALP emission filter (all
from Omega Optical Corp., Brattleboro, VT, USA). The GFP filter cube contained a
470/40 excitation filter, 485 LP mirror, and a 525/50 emission filer (Filter series 49002,
Chroma Corps, Bellows Falls, VT, USA). Images were acquired using a Hamamatsu
ORCA ER camera (Hamamatsu, Hamamatsu City, Japan) and NIS Elements BR 3.1
software (Nikon Corps, Melville, NY, USA).
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5.4.2 CHO Cell Culture
CHO cells were grown on coverglass (12.0 mm, size 1.0) until they were 70%
confluent. They were maintained in Hams F-12 media containing 5% serum at 37 °C and
5% CO2.
5.4.3 Live CHO Cell Imaging with Oleic TBA and Cy-3 DHPP
CHO cells were incubated in their home media with 10 µM Oleic TBA for 15
minutes at 37 °C. Cells were removed and then mounted in 12 mm perfusion apparatus
(Warner Instruments, P-3, RC-25, Warner Instruments LLC, Hamden, CT, USA) and
were bathed in extracellular recording buffer. Cells were irradiated with UV light for 15
seconds. After irradiation, 400 µL of a 1 µM Cy-3 DHPP for 30 seconds and then washed
for 2 minutes with extracellular solution via perfusion. Fluorescence images were then
taken using the Cy-3 filter cube. Controls were performed in the same way by using
DMSO in place of Oleic TBA.
5.4.4 Live CHO Imaging with Oleic TBA and Cy-3 DMAPP
CHO cells were incubated in their home media with 10 µM Oleic TBA for 15
minutes at 37 °C. Cells were removed and then mounted in 12 mm perfusion apparatus
(Warner Instruments, P-3, RC-25, Warner Instruments LLC, Hamden, CT, USA) and
were bathed in extracellular recording buffer. Cells were irradiated with UV light for 15
seconds and 250 µL of 1µM Cy-3 DMAPP were applied for 30 seconds. Cells were then
washed with extracellular solution via perfusion for 5 minutes. Fluorescence images
were then taken using the Cy-3 filter cube. Controls were performed using DMSO in
place of Oleic TBA.
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5.4.5 Live CHO Cell Imaging with Oleic TBA and Biotin-DMAPP
CHO cells were incubated in their home media with 10 µM Oleic TBA for 15
minutes at 37 °C. Cells were removed and then mounted in 12 mm perfusion apparatus
(Warner Instruments, P-3, RC-25, Warner Instruments LLC, Hamden, CT, USA) and
were bathed in extracellular recording buffer. Cells were irradiated with UV light for 15
seconds, incubated with 250 µL of 1µM biotin DMAPP for 15 seconds, washed for 2
minutes with extracellular solution via perfusion, incubated with Avidin-FITC
(BioLegend, San Diego, CA, USA) for 2 minutes, and washed for 2 minutes again with
perfusion. Fluorescence images were then taken. Controls were performed with DMSO in
place of the Oleic TBA and with no UV irradiation.
5.4.6 Image Analysis of Fluorescence Images
Images were analyzed using ImageJ (U.S. National Institutes of Health,
Bethesda, MD, USA). Fluorescence was quantified using ROI (region of interest)
analysis over the whole cell areas. The images were background subtracted and the data
was quantified using GraphPad Prism (La Jolla, CA, USA).

121

5.5 References
1.Sletten, E. M.; Bertozzi, C. R., Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of
Functionality. Angewandte Chemie-International Edition 2009, 48 (38), 6974-6998.
2.Patterson, D. M.; Nazarova, L. A.; Prescher, J. A., Finding the Right (Bioorthogonal)
Chemistry. ACS Chemical Biology 2014, 9 (3), 592-605.
3.(a) Dehnert, K. W.; Baskin, J. M.; Laughlin, S. T.; Beahm, B. J.; Naidu, N. N.; Amacher, S. L.;
Bertozzi, C. R., Imaging the Sialome during Zebrafish Development with Copper-Free Click
Chemistry. Chembiochem 2012, 13 (3), 353-357; (b) Baskin, J. M.; Prescher, J. A.; Laughlin, S.
T.; Agard, N. J.; Chang, P. V.; Miller, I. A.; Lo, A.; Codelli, J. A.; Bertozzi, C. R., Copper-free
click chemistry for dynamic in vivo imaging. Proc. Natl. Acad. Sci. U. S. A. 2007, 104 (43),
16793-16797; (c) Laughlin, S. T.; Baskin, J. M.; Amacher, S. L.; Bertozzi, C. R., In vivo imaging
of membrane-associated glycans in developing zebrafish. Science 2008, 320 (5876), 664-667.
4.Vodovozova, E. L., Photoaffinity labeling and its application in structural biology.
Biochemistry-Moscow 2007, 72 (1), 1-20.
5.Mahouche-Chergui, S.; Gam-Derouich, S.; Mangeney, C.; Chehimi, M. M., Aryl diazonium
salts: a new class of coupling agents for bonding polymers, biomacromolecules and nanoparticles
to surfaces. Chemical Society Reviews 2011, 40 (7), 4143-4166.
6.Kieffer, B. L.; Goeldner, M. P.; Hirth, C. G., Aryldiazonium salts as photo-affinity labeling
reagents for proteins. Journal of the Chemical Society-Chemical Communications 1981, (9), 398399.
7.Song, W.; Wang, Y.; Qu, J.; Lin, Q., Selective functionalization of a genetically encoded
alkene-containing protein via "Photoclick Chemistry" in bacterial cells. J. Am. Chem. Soc. 2008,
130 (30), 9654-+.
8.Poloukhtine, A. A.; Mbua, N. E.; Wolfert, M. A.; Boons, G.-J.; Popik, V. V., Selective
Labeling of Living Cells by a Photo-Triggered Click Reaction. J. Am. Chem. Soc. 2009, 131 (43),
15769-15776.
9.Yao, J. Z.; Uttamapinant, C.; Poloukhtine, A.; Baskin, J. M.; Codelli, J. A.; Sletten, E. M.;
Bertozzi, C. R.; Popik, V. V.; Ting, A. Y., Fluorophore Targeting to Cellular Proteins via
Enzyme-Mediated Azide Ligation and Strain-Promoted Cycloaddition. J. Am. Chem. Soc. 2012,
134 (8), 3720-3728.
10.(a) Sklar, L. A.; Hudson, B. S.; Simoni, R. D., Conjugated polyene fatty-acids as fluorescentprobes - binding to bovine serum-albumin. Biochemistry 1977, 16 (23), 5100-5108; (b) Wilton,
D. C., The fatty-acid analog 11-(dansylamino)undecanoic acid is a fluorescent-probe for the
bilirubin-binding sites of albumin and not for the high-affinity fatty acid-binding sites.
Biochemical Journal 1990, 270 (1), 163-166.

122

11.(a) Jeon, O.-H.; Kim, D.; Choi, Y.-J.; Kim, S.-H.; Choi, W.-S.; Kim, D.-S., Novel function of
human ADAM15 disintegrin-like domain and its derivatives in platelet aggregation. Thrombosis
Research 2007, 119 (5), 609-619; (b) Lin, H.-Y.; Yang, Y.-T.; Yu, S.-L.; Hsiao, K.-N.; Liu, C.C.; Sia, C.; Chow, Y.-H., Caveolar Endocytosis Is Required for Human PSGL-1-Mediated
Enterovirus 71 Infection. Journal of Virology 2013, 87 (16), 9064-9076.
12.(a) Anchordoguy, T. J.; Carpenter, J. F.; Crowe, J. H.; Crowe, L. M., Temperature-dependent
perturbation of phosphlipid-bilayers by dimethylsulfoxide. Biochimica et Biophysica Acta 1992,
1104 (1), 117-122; (b) Yu, Z. W.; Quinn, P. J., The modulation of membrane structure and
stability by dimethyl sulphoxide (Review). Molecular Membrane Biology 1998, 15 (2), 59-68; (c)
Notman, R.; Noro, M.; O'Malley, B.; Anwar, J., Molecular basis for dimethylsulfoxide (DMSO)
action on lipid membranes. J. Am. Chem. Soc. 2006, 128 (43), 13982-13983.
13.Smondyrev, A. M.; Berkowitz, M. L., Molecular dynamics simulation of DPPC bilayer in
DMSO. Biophysical Journal 1999, 76 (5), 2472-2478.
14.(a) Cunningham, C. W.; Mukhopadhyay, A.; Lushington, G. H.; Blagg, B. S. J.; Prisinzano, T.
E.; Krise, J. P., Uptake, Distribution and Diffusivity of Reactive Fluorophores in Cells:
Implications toward Target Identification. Molecular Pharmaceutics 2010, 7 (4), 1301-1310; (b)
Baumgart, T.; Hunt, G.; Farkas, E. R.; Webb, W. W.; Feigenson, G. W., Fluorescence probe
partitioning between L-o/L-d phases in lipid membranes. Biochimica Et Biophysica ActaBiomembranes 2007, 1768 (9), 2182-2194.

123

CHAPTER 5
FUTURE DIRECTIONS AND CONCLUSIONS
6.1 Conclusions for Nanoprobe Project
Our experiments with nanoprobe 1 suggest that this photolabile polyamine probe
could be potentially targeting calcium permeable AMPARs. This was based on our
promising imaging data which showed fluorescence accumulation in areas where
AMPARs are known to aggregate and the fact that known AMPAR antagonists could
block fluorescence accumulation. However, using SDS-PAGE analysis of neuronal cell
lysate labeled with nanoprobe 1 multiple bands were observed (Section 2, Figure 2.9).
Taken together, these results suggest that we needed to develop a probe that would be
better targeted towards calcium permeable AMPARs.
To allow for identification of specific subunits, we developed nanoprobe 2 which
simplified our synthetic design and resulted in a probe which more closely resembles the
natural toxin. We also designed nanoprobe 2 so that it would be amendable for proteomic
experiments. Nanoprobe 2, much like nanoprobe 1, relies on an acrylamide electrophile
to bioconjugation to the surface of the receptor. In preliminary imaging experiments, we
were able to target the same receptors as nanoprobe 1 as the fluorescence accumulation
looked to be similar. We then moved into doing pull-down experiments with nanoprobe
2 labeled neuronal proteins. The result of the gels is that nanoprobe 2 did not label
proteins like we saw with nanoprobe 1. This could be due to the electrophile not being
able to find a suitable nucleophillc partner to be able to bind on the surface of the protein.
We then decided to keep the same probe design, but swap out the electrophile for
nanoprobe 3. In this design, we used an aryl azide for our electrophile. The
photoactivated aryl azide is more reactive than the acrylamide, 1 so finding a suitable
nucleophilic partner should not be an issue. Initial testing of nanoprobe 3 in soluble
protein showed that the photolysis and click chemistry conditions work. Moving into
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neuronal proteins, nanoprobe 3 was, however, found to not bind either. Aryl azides are
indiscriminate in their reactivity, and tend to react to their nearest neighbor. In this case,
it is possible that the nearest neighbor was a water molecule inside the binding pocket
and not the C-H of a proximal amino acid. Without the covalent attachment to the C-H
of the nearest amino acid, nanoprobe 3 would simply be washed away by the many wash
steps involved in the pull down experiment.
One of the main reasons for why neither nanoprobe 2 nor nanoprobe 3 was able
to covalently conjugate to the receptor was mainly due to the position of the electrophile.
In nanoprobe 1 the electrophile and the targeting polyamine ligand were separated far
from each other as they were on either side of the ANI core. In both nanoprobe 2 and
nanoprobe 3 the ligand and the electrophile are much closer to each other, as the ligand is
eighteen bonds away from the electrophile in nanoprobe 1 and only nine in nanoprobe 2,
eight in nanoprobe 3. This placed the electrophile closer into the ligand binding pocket,
thus it might have not been able to find a good nucleophilic binding partner or would just
bind to water. One way to remedy this would be to move the electrophile away from the
targeting ligand.
6.2 Future Directions for Nanoprobes
One of the ways that our nanoprobes can be redesigned is already occurring in
the Chambers lab. This is through the use of modular nanoprobes that are able to
undergo click chemistry for ligand attachment. The core of these nanoprobes is the same
as nanoprobe 1, except there is an alkyne handle in the ligand attachment point. (Figure
6.1) Attachment of the targeting polyamine ligand has been a very tricky synthetic step
in the synthesis of all nanoprobes, but there are other targeting ligands available. These
ligands are not polyamine based but still act as use-dependent open ion channel blockers
of AMPA receptors and they include molecules such as IEM 1925 and GYKI 52466
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(Figure 6.1). These molecules both contain primary amines which could be modified
using a small acyl chain containing an azide for attachment to the nanoprobe scaffold
through click chemistry methods. This would provide us a few new targeting molecules
which keep the electrophile in the same position as nanoprobe 1.

Figure 6.1: Structure of alkyne nanoprobe. A) Structure of alkyne nanoprobe, ANI core
(pink) is attached to a carboxylic acid (green) for fluorophore diversity, and an
acrylamide electrophile (red). The alkyne handle (blue) allows for ligand
diversity. B) AMPA receptor antagonists IEM 1925 and GYKI 52466.
6.2.1 Probe Design of Nanoprobe 4
One of the main reasons we chose the polyamine targeting ligand was due to the
ability of the class of toxins to act as antagonists for calcium permeable AMPARs. A new
probe containing a polyamine would need to move the ligand away from the electrophile
in order for the electrophile to be able to explore similar chemical space to that of
nanoprobe 1. One way of doing so is to use naphthaleneacetic acid as our core for
attachment of our electrophile, ligand, and reporter tag. (Scheme 6.1) Naphthaleneacetic
acid would first be nitrated and the nitro reduced to an amine for another attachment
point. TriBoc spermine can then be peptide coupled to the carboxylic acid. Tert-butyl 5((4-acrylamidobutyl)amino)-5-oxo-2-((prop-2-yn-1-ylamino)methyl)pentanoate would be
synthesized from Boc-Glu(OMe)-OH, propargyl bromide, and 6-acrylamidohexanoic
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acid. This would then be peptide coupled to naphthaleneacetic acid to produce
nanoprobe 4.
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Scheme 6.1: Proposed synthesis for nanoprobe 5

6.2.2 Quinoxaline Dione Probes for Calcium Permeable AMPAR Detection
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Figure 6.2: Quinoxaline diones
Quinoxaline diones are another class of AMPA receptor antagonists. These
include CBQX, DNQX, and NBQX. (Figure 6.2) Potential probes for the detection of
calcium permeable AMPARs could contain quinoxaline diones, specifically CBQX and
DNQX, as targeting ligands. One way of doing so, would be to attach an azide
containing alkyl chain to the quinoxaline dione and then attach that to either the
nanoprobe scaffold, or to the ortho-triazene benzoic acid scaffold.
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6.3 Conclusions to the Photogenerated Diazonium Probes
With our photogenerated diazonium probes we wanted to target photolabile
bioorthogonal probes to the cell membrane. This was done in an attempt to develop a
probe that would have spatial and temporal control of reporter tag attachment to the probe
in order to observe biological processes. We chose oleic acid conjugated to ortho-triazene
benzoic acid to target towards biological membranes and an electron rich aromatic
reporter tag. Our first version of the reporter tag used dihydroxyphenyl piperazine
(DHPP) conjugated to Cy-3. This reporter tag proved to be membrane permeable as
control samples that only contained DMSO also had fluorescence activity. We then
altered the nucleophilic reporter to dimethylaminophenyl piperazine (DMAPP)
conjugated to Cy-3 as our electron rich aromatic ring. As with the DHPP conjugated
reporter tag, the DMAPP reporter tag also crossed the cell membrane in DMSO controls.
This could be due to DMSO causing permeablization of cell membrane allowing for the
reporter tag to cross the membrane.
We next decided to use a reporter tag that was conjugated with biotin in order to
see if the initial concept of photoinducible cell tagging was occurring and was detectable.
Biotin was chosen because it can be targeted with an avidin labeled fluorophore, which
should not cross the cell membrane. When the targeting probe was photoactivated, the
biotin reporter probe will bind, and then be targeted with the avidin-labeled fluorophore.
We see this with the new version of the DMAPP probe. Fluorescence is seen only in the
UV irradiated samples that contain the probe.
6.4 Future Directions for Photogenerated Probes
One of the main issues that needs to be perfected for the continued use of the
photogenerated click probes is the targeting fluorophore. The two scaffolds that were
tried were also taken up by the DMSO sham controls cells. These cells had fluorescence
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accumulation that was equal to that of the ones that contained the targeting probe. If these
probes are to be used further for imaging experiments, the use of a targeting probe that
contains a fluorophore that does not cross the cell membrane would be crucial. One way
to do so might be to use dyes that are more hydrophobic so they would have a harder time
passing through the membrane.
The preliminary work with the photogenerated probes suggests that we can label
live cells with our probes in a short time scale. The probes in this case are not ligand
directed; rather they are attached to a long chain fatty acid for incorporation to the cell
membrane. The next step for these probes would be to attach a targeting ligand to target
fluorescence to a particular receptor.
Since we are interested in AMPARs in the Chambers lab, the logical targeting
ligand would be one that targets towards AMPARs. The ortho-triazene benzoic acid
portion of the targeting probe contains an alkyne handle for ligand attachment, so an
azide labeled ligand can be attached. In this case, we would try the same panel of azide
labeled ligands as listed in Section 6.2 and 6.2.2. (azido IEM 1925, azido GYKI 52466,
or an azido containing quinoxaline dione (Figure 6.3)). The acyl azide chain attached to
GYKI 52466 is to the pendant phenyl, or as the pharmacophore dictates. Once these
probes are synthesized, they can be applied to GluA1 CHO cell and then neurons to see if
we can use this new photoclick method to target receptors.
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